FBC Lett., No. 45 (2014)

2014  7 

2  

夢への責任

4 

大阪府立大学大学院理学系研究科

藤井 郁雄



4 RNA ワールドから iPS 細胞へ -生命起源と細胞構築原理の探求京都大学 iPS 細胞研究所 白眉センター
齊藤 博英
9 バクテリア融合チャンバー -細胞の再構成に向けた人工物との融合田端 和仁
東京大学大学院工学研究科

14   
14.

京都大学大学院工学研究科

博士課程１年

18.

東北大学多元物質科学研究所

博士課程２年

21.

25  九州大学大学院薬学研究院

助教

河﨑

陸

上松 亮平
田畑 栄一

カリフォルニア工科大学留学体験記

Division of Chemistry and Chemical Engineering, California Institute of Technology

30   

田村 朋則

第８回 バイオ関連化学シンポジウム

第 41 回 国際核酸化学シンポジウム（ISNAC2014）

第 24 回 バイオ・高分子シンポジウム

14-1 バイオ・高分子研究会

人工光合成国際会議 2014
第 17 回 生命化学研究会
受賞、異動

編集後記

1

   No.45 (2014 July)










 

2008&Ñoßä^ HOPE?>Ñoßä^&²{9ħfgÕ!
Đ.¿201457åĩ¾

×=#ĄĂħ.
m<

BCQF!ħX¾'^ė<­8#&%7.

b7!ď1!9)#î!

ġõ.##"ħ¼h'YV)ħĢdÈ~"

6Ī

7.'"ħ$5:Ğý'æ&%7.'º¾'þĠ#ħSTAPéò(.=!ħX'Ĥn"â§'(ħßäï'ćĉ"$=%W

ßäï&|!8ī ā,!/8#'ćĉ#óm°69!.

ÑºZ&Ā=ö³ï'>LM@ĥøqÇ÷/µË´Ħ#¿&(ħßäï&û%ćĉ#!4'#»

9!.'ćĉ#(ħÞÖ8#ħĔ

8#ħÅüÖ"8#ħ!¬"8#'4"96(ßäï'<Ē¨8
1'ćĉ<©2'"4ßäï'YV('8ñÃ"ßä&5!ħ9."
ă#¢!'VÁ'¿ĉ

¹6

&9!

.9."'ßä&!ħ,!

&Ĉz8'"(%ħªiÖ%èá"ħ9."#(ēüÌ
8#ħ96µĂÐ3î<lĎ

ßäï'YV%'"'¦~"ßäñ#(ĔÖ"'8ñÃ"¸Ù%ÞÖ#ħ"2vó£=%WÎ&]98,9);78¬ħ9<a!Ô;%Wħ

YV#.&8ćĉ&

!(ħOw(yÂ"R¶ħßäñ(pę%cĝ<®ñÃ"27.%%6ħßä#(ħâ<u7à^ÑÊ#ě9Óĉ'2'<}=Ïj%YVò&:ħÓĉ%2''S%
đ&(6"iPSéò&:STAPé

6ħßäï'RW#!ħX'ENG%$'JBAK%ē§<§.ßäï(ħà^#ôċ#'Ę&R'Ċě<9).=%9)ßä¨À

6ëÖ%ü£

!ßä%;98#&%7.

'Ċě<`#(ħ=%&Ĝ#"(%("ĥÇÛ%#:ħ¼Č(êÆĜ
%!

!.

…Ħ0:ħßäï

·Ö&ù!8#"7ħ.7ÿ698#(7.=#(ýħ'R'Ċě%9)ħßä'Sx'[3ĕĖÖ%kØ'_U&5!ßäï'2Ć](ħ9r!.#&%!.'"$'5%ÐÒ
'ħXħRß2Ow2à^+Č



!Ċě§<

9!.5"ßäï'YV(ħ#Ć]#Ĩ'Üt8£ĉ<2ħÄ1!pę%ñÃ%'"

2 
ßäï(ħ+'Ć]<ą!.ģ%±ä#À!%¤Í"ħ."2<čì8#ħ!ħ9&#2%Ć]<É!
,

9%W'W

%'"X)6(ħĚ^Ą+ù*&ħX'TÇĠ

e½ħgĚ^Ą"sW

  No.45 (2014 July)ßä<Ú¯

þĠ&'-7.

6·¿'ã«ú'ağ<dOw'í(#ý;99<ð!â(T¥¡%¢<85720:ID#.X'#(Ow'Ġ"7ħ9."2!X2·¿'ã«ú'ağ(.`9!8ç!
9\Sd

%5ħ'Ĥn&ÉÝ#<ġ)ağ

7"
20146½



3

 

ýUEvĎĖǾǞȃƏ Ə No.45 (2014 July) *,)(!%  $
-



"



#-


   

&+',

hirohide.saito@cira.kyoto-u.ac.jp
1. ƹ ƥǀ ƶ ȉRNA ƳƸ 4  ƗƏ ƔxzƸÔƱƹƴƘƵƮƱƗǆƸƛȊýUƹxzƸƴơƲƑƴƸǃƘƶŐýƤƫƸƛȊƕxzǂýU
ƸśïƸYƇƶżƤƱƑÕïĆƵĶTǊǁƮƱÑmvvŰƶŨvƤƫđƹƑÂEvýUvēƶƚǄǇƫìŠ1ĭ.ýƸĎĖ~ƶŲƣǇƑRNA Ƴ4ƮƫƒìŠ.ýƸ5týôvƸ³×ƹÂƸđƶƹƁƤƞƑlƞƸơƳƹûŇƲƝƵƛƮƫƸƬƜȅƦƗƾƨǋȆƑƩƸƲƔRNA ȀȃǽǥƕƳƗƘŒǊčƮƫƒƔýUƹĵŁŀĴƳňqßĴǊ!ƨ®Ʈƫ RNA ƛǄpƾƮƫƕƳƦǆŒƹƳƱǁƍ?ĆƲƑ
RNA ƸĎĖƲýUśïƸûŇƜŨǀƺƄąƗȄƳƞ£ƥƫƒƩƸƑƸǄǅƞǄǅƳŪƢƤƱƗƫ(iœĕƸÂƶƑǌǶǼǑƸ Jack Szostak Giǂ David Bartel GiǄƜ4Ƥƫ RNA ųĥƸōƋĜ3ŨE|ƋƶżƦǆŕ»ƶňĄƣǇƑGiœĕƼŨvƦǆſƶ RNA |ƋŨEçǊvƻƫƗƳ

ƗƑÂǧǸȃǺȃǓ

ĘmvƶƚǄǇƫƑSzostak Ď4ŝƸĺĿÁ.ýƶǶȃǽǊÆƗƫƒĺƣǋƛǄƔǌǶǼǑƶÐƱǁƗƗ
ǃƕƳƗƘŢ

ǊǁǄƙƫƳƝƹƳƱǁsƤƞƑĵ5Ƹ=ƶ½ƤƗĀƜźƟƱƗƞãƜƤƫƒǌǶǼǑƲƸǌǪ

ȃǤƜŃƯƛǆƾƲĺƣǋƸĵwƶŧŻĕæǀƱƗƫƬƟǆơƳƶƵƮƫƜƑƯƸYƇƜýƥƫƒđ
ƹÂǯǫȃǛǷȃǑȃƬƮƫƜƑìĢ=ƶĺƣǋƛǄƂŎƲƔƎĻRƹǞǩǖƦǉƵƗǃƷȊƕƳĲƛ
ǇƫÂƶȅĺƣǋƜǞǩǖrƗƳƗƘơƳƹưƱƶĲƗƱƗƫȆ

ǉƧƔƹƗǁƭǈǋƲƦȄƕƳěƙƱƤ

ƾƮƫƸƲƖǆƒ|ƹ¦ÿėîƲǞǩǖƸǑȃǤȁǊĝƛřƗƬǀƤƱƗƫƸƬƜƑĪƑƉĽßƶ

ǆ

Ċ=ƶƩƸǑȃǤȁǊ0Ű²ƱƫƒƩǇƜƾƲƸĵ5ƳƸå9}ŉƲƖǆãƜƤƫƒǞǩǖƸǑȃǤȁǊ
ǗǴĝƶ¬Ơ²ƱƫǙȃȁƹǁķƞńƙƱƗǆƒìĢƹƑǁǉƛǄƵƗ½IıǊĺƣǋƹĆƶǤǾȃǧȁǔƤƱƞƬƣǅƑ RNA ųĥǊōƋĜ3ŨEƣƨǆĎĖǊƹƥǀƫƒÂđƹůÄMƸśï
ƶ RNA ųĥƜżƤƫKĴ¡ƶĶTƜƖƮƫƒƩơƲƑtRNA ƶǌǴǨŴǊŞĔƦǆJǊňqƦǆÈǁ
HpĆƵųĥƸƯƲƖǆƑǌǴǨǌǙǽ tRNA N¦ųĥƸ,ƝǊÝ*Ʀǆ RNA ųĥƸŨE|ƋǊŨǀƫƒ|ƋŨEƸŪĕƲýƥƫ RNA ųĥƸßĴǊŔƽƫ RI ǕǽǊ8ǀƱŃƫÂƹƑ£DƤƫƒǻȁǟǵƵ
Ų7ƛǄŨEƤƫ RNA ƹƑƃƶoƶǌǴǨŴƳ tRNA ǊŏŗƤƑǌǴǨŴŞĔJǊňqƲƝǆƳƗƘ
ơƳƜǉƛƮƫ

1,2,3ƒơƸékƲƸĎĖĩƋƜƑƸĎĖýèƶm

ƶƹƑÎĿƣǋǂĠbČ

ƵơƳǊ·ƙƱƞǇƫƒÂƸĺĎƣǋƜǲǛǥǓƳƤƱIAƤƱƗƱƑƿǋƵƲâÀĸƓƳǣǍǛǑǡǙǹȁǊƦ

ǆƸƹƑƶǁƙƁƗÙƤƗĩƋƬƮƫƒƩƸć÷ĘƤƫƜƑǁƮƱĸƓƳŎƦơƳƜķƗ<ñƳƵƮƱƗǆƒm5=ĮƝƜŹƞƵƮƱƤƾƮƫƜƑơƸĩƋǊ-ƶđƹúaƔRNA Ǌ>ǆƕơƳƶżŦƤƫĎ
4ĖǊĽƮƱƗǆ ƒƩƸ3ƶƯƗƱħƤƫƗƒ

4ýUEvĎĖǾǞȃƏ Ə No.45 (2014 July)
2. RNA-Ǟȁ Ǫ ǓŚ ċ þ Ʋ ů  t ǛǎǡǠ Ǌ > ǆƏ `ƶăĎĖ¨ƸĹëžŰŹƸǁƳƲǞȁǪǓŚƸŨE5tvƳXƈĦĳǊþƗƫ|Ƌªľ

5ǊvǋƬđƹƑRNA ƳǞȁǪǓŚǊĨƿNǉƨƫĎĖǊƤƫƗƳİƙƱƗƫƒƩơƲ 2005 ƸĒƶűmvýUēvĎĖēƸ.ýƸĎĖ~ƶB©ƳƤƱŲƣƨƱƗƫƬƗƫƑRNA ƳǞȁǪǓŚƸċ
þǊ:þƤƫįŌ;ªľ (RNA ǛǎǡǠ) ƸźĄǊpǀƫƒƏ ơǇƾƲƶƑnóƸ mRNA Ɯ5tƶěƤƱůtĄúǊŔĞƦǆßÚƑǼǱǛ
ǎǡǠƜĄŃƣǇƱƗƫƒƾƫƑƩǇ=ƸĎĖƲǁƑRNA ƳǞȁǪǓŚƸċþǊdĈƳƤƫįŌ;Ƹ"ƹčǄǇƱƗƫƒ
§ƓƹơǇǄ.ĽĎĖǊIİƶƑĦĳ3ƲĄúƦǆǞȁǪǓŚǊÖčƤƱƑůtĄúǊǖȁǤǿȃǽƲƝǆƸ RNA ǙǛǢ
ǵ (RNA ǛǎǡǠ) ǊźĄƤƫƗƳİƙƫƒ
ƦƵǉƭ RNA ǛǎǡǠƳƹƑÜĆĦĳ3ƲĄúƦǆõ{Ƹ[t (ǞȁǪǓŚƵƴ) ƶ% #'

ěƤƱƑįŌƸǐȁȂǐǭǊ6ǅÇƙǆ*)%

ĨƿƸơƳǊ¯Ʀȅ^ 1 ȆƒơǇƜ|úƲƝǇƺƑýƝƫĦĳ3Ƹö¤ƶƥƫǙǔǦǽ¢eƸjµǊ|úƤƑĦĳũUǊĵĆƶ;ƲƝǆKĴ
¡ƜƖǆƒƫƳƙƺƑĦĳ3ö¤ƸoƵūƗǊģƶŗ9ƤƑƩǇƶƥƱůtĄúǊĵaƶ;ƲƝǇƺƑƜǋEƤƫĦĳƶƸƿĦĳáőǙǔǦǽǊè¡EƦǆƳƗƮƫǃƘƶƑĦĳ3ö¤jDƶƥƫÜĆĦĳƸŮ9ǂũU;ƼƸþƜÊƲƝǆȅ^ 1 LȆƒơƸ RNA ǛǎǡǠªľźĄƸƫǀƑRNA
ƳǞȁǪǓŚƸõāĆċþƜèþƲƝǆƳİƙƫƒƩơƲ mRNA ǙǛǏǾǶȁǤƶĪNƦǆǞȁǪǓŚ

ƸßĴǊÝ*ƤƑįŌ;ǙǛǢǵǊŋŊȂÚĠƦǆơƳǊōƿƫƒƾƧƑmRNA Ƹ 5ƐƃįŌƆc
(UTR)ƶõ{ƸǞȁǪǓŚǊĪNƣƨǆơƳƲƑĉĆůtƸįŌǊCÔĆƶ«;ƦǆƔmRNA ǐǭǛǎǡ
ǠƕǊźĄƦǆơƳǊōƿƫƒĚıǄƹƑǼǱǝȃǵǞȁǪǓŚƸȇƯƲƖǆ L7Ae ƳƑL7Ae ƶõāĆƶĪN
Ʀǆ RNA ǷǠȃǭƲƖǆǒȁǓǞȃȁ RNA (K-turn)ƜįŌ«;ƸǷǚǸȃǽƳƤƱ:þƲƝǆơƳǊŃ46

Ƥƫ ƒơƸ K-turn Ǌ/Ƥƫ mRNA ƹ L7Ae Ƴ_ƵŁNǊ¦ƦǆƫǀƑL7Ae ǊĄúƦǆĦĳ3ƲƹƑÜĆ mRNA ƲƸǼǱǝȃǵßĴƜŽƣǇƑįŌƜCùǃƞ«;ƣǇǆƒơƸǃƘƶƔƗ«;ƕƬƟƲƹƵƞƑĦĳ3ö¤ƶƥƱįŌŷǊÛƓƵǾǰǽƲǖȁǤǿȃǽƦǆơƳƹKĴƬǈƘƛȊ
3. Ł ¹ mRNA Ƹ O Â ƛ Ư õ ā Ć Ƶ į Ō Ǡ Ǹȃ ǧ ȁǔƏ Èš§ƓƹƑX

ƈĦĳ3Ʋ mRNA ƛǄƸįŌŷǊģƶǠǸȃǧȁǔƲƝǆ½ƤƗ¾çƸźĄƶ¦@ƤƫƒơƸĨƿƸŸƳƵǆƸƹƑmRNA ǙǛǏǾǶȁǤƸǏȁǚǧǌǼȁǔƲƖǆƒƦƵǉƭƑÜĆǞȁǪ
ǓŚƶĪNƦǆ RNA ǷǠȃǭŲ7ƸƔmRNA ƲƸf¨Ƴ¹ƕǊjEƣƨǆơƳƲƑÛƓƵǾǰǽƲįŌ
7ŷǊŔĞƲƝǆơƳǊŃ4Ƥƫ (^ 2) ƒƾƧƑmRNA Ƹ 5ƐËęƛǄ RNA ǷǠȃǭŲ7ƾƲƸŜƀƳƑǷ
ǠȃǭƶĪNƦǆ;ǞȁǪǓŚƶǃǆįŌ«;CÔƳƸŻƶØǀƱƌƗċżƜƿǄǇǆơƳǊĄŃƤƫƒ
ƾƫƑơƸǷǠȃǭŲ7ǊŁ¹ŦĪƤƱ mRNA ƶ±/ƦǆƳƑƩƸ¹ƶƥƱƞįŌƜ«;ƣǇǆƒơǇ
Ǆ 2 ƯƸõǊĨƿNǉƨƑÜĆŲ7ƸǖǬȃ¹ǊhǂƤƱƀ¸ĆƶįŌ«;CÔǊƌǀƯƯƑ ¾

5

ýUEvĎĖǾǞȃƏ Ə No.45 (2014 July)Ʋ 5ƐËęƛǄÜĆŲ7ƾƲƸŜƀǊƺƤƱŦīĆƶįŌ«;CÔǊǀǆơƳƶǃƮƱƑ;[tƸuaƶƚƟǆįŌŷǊƗğ]ƲŔĞƦǆơƳƜƲƝǆƒ)ƓƸ4?ůtƸįŌCùƹ 5Ɛ UTR Ʋ
cis ƶ,ƞł[ƲåǀǄǇǆƸƲƑāƵǆŋŊƸ UTR ǊǁƯŁ¹Ƹ4?ůtƹƑȇƯƸ;[tƶǃƮƱƩǇƪǇÛƓƵŷƶŔĞƲƝǆƒƤƫƜƮƱơƸĨƿǊ:þƦǇƺƑOƥè¡ǊǁƯƯƸ/?Ǟȁ
ǪǓŚƸĄúƶƥƱƑŁ¹Ƹ mRNA ƛǄƸįŌǊƩǇƪǇÛƓƵǾǰǽƲŔĞƦǆơƳƜKĴƳƵǆƒ
ơơƾƲƑõ{ƸǞȁǪǓŚĄúƶƥƱƑůtĄúǊ«;ƦǆƔǐǭǛǎǡǠƕƸƹƫǄƝǊƿƱƝƫƒƲ
ƹţƶƑůtĄúǊè¡EƦǆƔǐȁǛǎǡǠƕƹƴƸǃƘƶÚĠƲƝǆƬǈƘƛȊ
(2)

mRNA
(1) 

(2)'









gene'of'interest(1)

RNA





'

$


(2)$

(1)$



%

.3"+$,

4. RNA ǎȁ ǩ ȃ ǞǷ ǚ Ǹȃ ǽ Ƹ ź Ą ȉǐ ǭƛ Ǆǐ ȁ Ƽ Ƹ 6 ǅÇ ƙ Ɯ mƏ §ƓƹƑġ%ƶ RNA ǛǎǡǠƸ¡ĴǊŔĞȂJŞƦǆ©çǊźĄƤƑƩǇǊ|úƦǆ RNA ƛǄƵǆ8ŰVǊƔRNA ǎȁǩȃǞƕƳPưƟƫ ƒZźĄƤƫ RNA ǎȁǩȃǞƹƑRNA ǛǎǡǠƸßĴǊ OFF ƛǄ
ON ƼƑƩƸÖ4ôŚƼƸõā¡ǂ£ǊĬ®ƤƫƾƾĵaƶjµƦǆơƳƜƲƝǆȅ^ 3ȆƒơƸ RNA ǎȁǩȃǞǊ±/Ƥƫ mRNA ƹƑĦĳ3ƲÜĆƳƵǆ[tƜĄúƤƱƗƵƗfNƑǦȁǜȁǛjā$u mRNA 5ŇßÚ (NMD)ƳƗƘúŘƶǃǅƑŤǂƛƶ5ŇƣǇǆƒơơƲÜĆ[tƜĄúƦǆƳƑmRNA ƹÜĆƶĪNƤƑƩƸĪNƶƥƱ NMD Ɯ«;ƣǇǆơƳƲ mRNA Ɯy{EƣǇƑĉĆƳƦǆk
ÐůtƸįŌǊè¡EƦǆƒƫƳƙƺþ"ƳƤƱƑƜǋĦĳƶõÉƸôŚȅ"ȉƜǋǳȃǑȃ[tƵƴȆƜƔƖǆƕƳƑƩƸĦĳƜáðƦǆůtȅ"ȉĦĳáőůtȆǊĄúƦǆ ON ǛǎǡǠƸÚĠƜİ
ƙǄǇǆƒƾƫƑơǇƾƲƸĎĖƲƹůtƸĄúǊ«;Ʀǆ OFF ǛǎǡǠƳƑè¡EƦǆ ON ǛǎǡǠƹ
÷Ęƶ¦ȂÈŭEƦǆłƜƖƮƫƜƑÌ©çƶǃǅX

ƈĦĳ3ƲƸůtǛǎǡǠƸ OFF Ƴ ON Ƹ

6ǅÇƙǊġ%ƶĽƘơƳƜƲƝǆǃƘƶƵƮƫƒƣǄƶƑơǇƾƲƸªľƲƹƑƯƸ[tƲŁ¹ƸůtƸĄúǊOÂƑƛƯ÷Ęƶ;ƦǆơƳƹ\ƁƲƖƮƫƒZƸ¾çƲƹƑmRNA 1 5t3Ƹ¶jƲƑǛǎǡǠƸ¡ĴǊŔºƤƫǅƑßĴǊJŞƣƨƫǅƦǆơƳƜƲƝǆƒƤƫƜƮƱƑ1 ƯƸ;[tƜŁ¹ƸkÐůtĄúƸǐȁȂǐǭǊ)9ƛƯOÂƶ;ƦǆơƳƜƲƝǆǃƘƶƵƮƫƒ

6ýUEvĎĖǾǞȃƏ Ə No.45 (2014 July)

ON'
.

.

 OFF(intron)
IRES
.





0

0

1

1

mRNA' (intron)
IRES ON

mRNA %
5. RNA-Ǟȁ Ǫ ǓŚ ċ Ə ůtǛǎǡǠ





5-

þ Ʋ Ǧ ǨÚ ť  Ǌ > ǆ¦ƶþƗƫ RNA-ǞȁǪǓŚċþƹƑǦǨÚťƸ5tǣǘǎȁƶǁ:þƲƝǆƒ

ơǇƾƲƶeSƣǇƫ L7Ae-K-turn ƸĪÃÚťƸ¢eƛǄƑL7Ae ƹƑK-turn RNA Ƹ­ƆcƸÚťǊ

Ĥ 60 ƶ_{ƦǆƳƗƘ¡ŚƜčǄǇƱƗƫƒơƸõǊ:þƤƱƑL7Ae-K-turn ǷǚǸȃǽƛǄƵǆ9ǦǨàņƸǣǘǎȁƳÚĠǊōƿƫ(^ 4 ) ƒƾƧƩǇƪǇƸŠƜƗƶċþƤƵƗǃƘƶƑȈ

ŠƸŲ7ǊŋŊƤƱƚƞƒƩƸȈƯƸƅòƶƹƑȈƯƸ K-turn ǷǠȃǭǊŲĮƣƨƫƒƤƫƜƮƱƑȈƯƸ
ƅòƶȈƯƸ L7Ae ǊŲĮƣƨǆơƳƲ 60 ƶ­ǇÅƜǅƑàņöƸǦǨÚťƜÚĠƲƝǆƸƲƹ
ƳİƙƫƒǣǘǎȁƤƫǦǨÚťǊ|ſƶ¦ƤƑƩƸÚťǊ AFM ƲŅíƤƫĪÔƑďƛƶ L7Ae ƸuaƲƸƿàņÛƸ RNA ÚťƜ¦ƣǇǆơƳƜďŏƣǇƫ (^ 4 L)ƒƮƱƑRNA ƳǞȁǪǓŚƛǄƵǆ 1 ŠĤ 10nm ĕƸǦǨņƸŋŊƳŀƶ¦@ƤƫƒơƸǦǨņƸ:þçƳƤƱƑÛƓƵßĴ¡ǞȁǪǓŚǂßĴ¡ RNA ǊƑģƵŜƀƳŲQ¡ǊǁƮƱŲĮƲƝǆơƳƜ°ƠǄǇǆƒ
§ƓƹơƸÚťƜĦĳ3ƸügƶƈƤƫýûÏƲǁy{ƶ'®ƲƝǆơƳǊ¿ƶďŏƤƱƗǆƒ

%4!0(217/&ýUEvĎĖǾǞȃƏ Ə No.45 (2014 July)
6. ƚ ǉ ǅƶ ȉRNA ª ľ Ƴ iPS Ħ ĳ ª ľ Ƹ ļ N Ǌ ĉ ¯ ƤƱđƹ2010ƶ÷ĘƤƑ2011ǃǅiPS ĦĳĎĖ¨ƲRNAǊǁƭƗƫĦĳßĴ;ƶżƦǆĎĖǊŨǀƱƗǆƒĦĳ5EǂĦĳǼǮǿǔǻǴȁǔƸŪĕƲǟǎǦǴǡǓƶjDƦǆĦĳ3ö¤Ǌ
RNAªľƲģƶŇÒƑ;ƦǆơƳǊĉ¯ƤƱĎĖǊŨǀƱƗǆƒơơƲħƤƫRNAǛǎǡǠǂRNA
ǦǨÚťƹƑǙȁǜǢǍǡǓǩǎǐǿǚȃǂǦǨǢǓǨǿǚȃ5ŶƶRNPȅRNA-ProteinŁNȆƳƗƘÍ¼
Ǌ´#ƦǆǁƸƲƖǆƒõ{ǞȁǪǓŚƸuaƲƸƿůtĄúƸ6ǅÇƙǂƑņǦǨÚťƸ¦ƜƚơǆƳƗƮƫǃƘƶƑügƶƥƫůt¢eȂÚťƸjµƜÊƲƝǆƒÐĆƶƹƑơǇǄRNA
ǂRNPǊ5tǳǢǼǌǽƳƤƱèþƦǆơƳƲƑýUǙǛǢǵÚĠHûƸûŇƶƯƵƜǆƔĦĳǷǣ
10ǽƕǂƑFĂþƶƯƵƜǆƔ5tǿǱǡǤƕ Ǌ>4ƤƫƗƳİƙƱƗǆƒ
ŖşƏ ÌĎĖƹƑűmv ýUēvĎĖē ·³ƑĻÿĐB·ƑmŶGĎĖWƑűmviPSĦĳĎĖ¨ ŬĻ¥ĎĖWƑŹÿäŵtĎĖWƑÞÿ&ĎĖWƑÓƊ+ªľWǄƳƸ2OĎĖƶdưƞƒ
ƾƫƑơǇƾƲlƓƢ¯ƞƬƣƮƫ0ƱƸćÛƑúĎĖ~Ƕȁǩȃƶêƞ£ŖƤƫƗƒ
»øȉ1.

Saito, H., Kourouklis, D. & Suga, H. An in vitro evolved precursor tRNA with aminoacylation
activity. EMBO J 20, 1797-1806 (2001).

2.

Saito, H. & Suga, H. A ribozyme exclusively aminoacylates the 3'-hydroxyl group of the tRNAterminal adenosine. J Am Chem Soc 123, 7178-7179 (2001).

3.

Saito, H., Watanabe, K. & Suga, H. Concurrent molecular recognition of the amino acid and tRNAby a ribozyme. RNA 7, 1867-1878 (2001).

4.

Saito, H. & Inoue, T. Synthetic biology with RNA motifs. Int J Biochem Cell Biol 41, 398-404(2009).

5.

Saito, H. et al. Synthesis of functional proteins by mixing peptide motifs. Chem Biol 11, 765-773(2004).

6.

Saito, H. et al. Synthetic translational regulation by an L7Ae-kink-turn RNP switch. Nat Chem Biol6, 71-78 (2010).

7.

Endo, K., Stapleton, J.A., Hayashi, K., Saito, H. & Inoue, T. Quantitative and simultaneoustranslational control of distinct mammalian mRNAs. Nucleic Acids Res 41, e135 (2013).

8.

Endo, K., Hayashi, K., Inoue, T. & Saito, H. A versatile cis-acting inverter module for synthetictranslational switches. Nat Commun 4, 2393 (2013).

9.

Ohno, H. et al. Synthetic RNA-protein complex shaped like an equilateral triangle. Nat Nanotechnol
6, 116-120 (2011).

10.

Hagiya, M., Konagaya, A., Kobayashi, S., Saito, H. & Murata, S. Molecular Robots with Sensors
and Intelligence. Acc Chem Res 47, 1681-1690 (2014).

8ÑH2[àêǈƪǌř ř No.45 (2014 July)# "%!$&#'
(




(


 

 

kazuhito@nojilab.t.u-tokyo.ac.jp
1. ƃŰƍƁř ř ÑËƂ¥e°5ƃòĀŽŠƔŜÑHæ[ÿƃśŵƂòĀŦR¸ů)ĕűƔ±ƘĘżÑŧËƒů
ŮƘŰśƋŷŹŦźżŨƔÖJśŞÑËžƃƀƙŶƏşžšŢJšƁíţƔƈŨśàêƁĸĴůżŧŷŜ

ŬƕƋŽƂÑË[ŽđźżŧŷàêƃśķYƘB]ůśƪǋƷƞħƂ´āƘģƈśŵƕƒŦòĀƂŽſƂƑŢƀƳƬƯǊǌƞƘƓòĀ´āƘ×ÏűƔƂťžšŢàêŽŠƖŢŜŵůżśŬƕƒƂŇĳƘŻŲŻƒťƁůś¥óÙƁƃòĀƂƝƪǉƟƘűƔžšŢƑŢƀàêŽƃƀšŸƖŢťŜŵƂŽƎƾƜǇƦ
ƯǌǋžƑƆƈŧƃś"ơƴǀƂĚĢŽŠƖŢŜòĀƂ"żŦ£ŧĭƋƕżšƔơƴǀƘĚĢűƔĒƘƁůŷõ«śòĀƂƝƪǉƟ2ƁjƂĪŦťťźŷƑŢƁƗƕƔŜĮpƃśĒƏƢǋƸǄǌƪǌƂĜî
ā.ƂĎůšCƁƑźżśùüÙƁơƴǀƏī'ÒËśƪǋƷƞħƀſƘģƈƔàêŦ>ŒůżšƔŜŵ
Ƃõ«śÑHƤƦƭǀžůżƂòĀƂÐĚƁŦhŧŻŻŠƔžšźżƎššŸƖŢŜžƃšţśòĀƃ¨ŸƺǅƬƞƼƬƞƦŽŠƓśŝƃŦòĀƂÑËƒůŮƘÑƙŽšƔƂťƘÐĚŽŧżšƀšŜŵŬŽśÑ
Ë[ŦµƁÚűƈŧÚ²ƃŞ-ƔŬžşŽƃƀšťžŢŜõgƂśšŨƒƝƪǉƟƘ^ŮųŷžŬƖŽś
ÝƁÑËƘÐĚŽŧŷťžšŢžśŵƕƃDŽŠƔžþţƔŜŵƂƝƪǉƟťƒĖñƘŧ(ůśŝƂ´āƘ&ÏŽŧƔťƘ­ğůśŵƕƘƁůš´āƘ-Ɠ(űŬžŦŽŧżÐĚůŷžšţƔƂŽƃƀšŸƖŢ
ťŜŵůżś-ƔŬžƂƁŠƔƎƂƃVŧƀTŏŽŠƔŜĥÙƁƀźżůƋźŷŦśÉ´2[Ə¦´2[Ƃ×iƘþţżƉůšŜŬƕƒƃ-ƔŬžŦŽŧƔæ[ŽŠƔŜŵƕƒƂ2[ƁƑźżÑƌ(ŮƕŷƎƂ
ƃśÒ®ŏHƘtŧĩŬůśŝƂÑ½ƘTŮųŷžšźżƎĵěŽƃƀšŜƐţƁśÑË[ƁŬƕƋŽ
!ŮƕżŧŷĦłƏ

ÙĦÃƘÑťűŷƍƁƎśÑË[ƃ-ƔŬžŦŽŧƔ[JƁƀƒƀŨżƃƀƒƀ

šŜ

2. šťƁòĀƘ-Ɣťř ř ř òĀƘ-ƔžšŢŬžƁŇůżś¥Į¥ƎĠœƁƀźŷƂƃśCraig VenterƒƁƑƔƾƜƢƻǅƧƾơƴǀ
Ƃ"AžśŵƂd!ŽŠƖŢ[1]Ŝzƒƃś1MbpƁ:ƆMycoplasma mycoidesơƴǀƘ\"Ɓ2[AůśĺTƘ0ţżśŵƕƘ*èƂƾƜƢƻǅƧƾǍMycoplasma capricolumǎƁd!ůśMycoplasma
mycoides JCVI-syn 1.0ƇƓ¤ţƔŬžƁ/ůŷŜŬƂàêƂGűƔžŬƖƃśơƴǀƘƮƣƜǋűƔŬ
žŽśůšòĀƏÑËƘ-ƔŬžŦŽŧƔ=āƘäůŷžšŢŬžŽŠƔŜŬƂàêŦäůŷƑŢƁśơƴ
ǀƘ-ƔŬžƎśòĀƘ-Ɣ¼ƂŻŽŠƔŦśŬƕƃòĀƘ-ƔŽıĵÈƂŻŽŠƔžþţƔŜê¯ÙƁƃśòĀƁĖƀĖñŽŠƔƪǋƷƞħƏ2[ËħƀſƘØťƒ4Ŋƍś1ƝƁńŰŬƍƔŬ

9ÑH2[àêǈƪǌř ř No.45 (2014 July)žŦòĀƘ-ƔŬžŽŠƔŜŬƂ¼ƃ°ÙƛƻǉǌƫžƑƄƕśŝƂĖñƘŻŲŻéƌūż-źżšŨŬžťƒśòĀƘ-ƔžšŢJœƁbůż±ŝƀCťƒƛƻǉǌƫŽŧƔŜŵƂŷƍś}ƒƕƔ
PƏÐĚƃžżƎUšŜůťůƀŦƒś^ŗƁŤšż»ƍƀŨżƃƀƒƀšƷǅǁǌƪǌƎcnŽƃƀš
ũƒšƁUšŜ·ÛƀžŬƖśòĀƘ-Ɣ¼žůżÏ¡ÈŽƃÏ^ÙžƃšţƀšŜŵůżśŵƎŵƎŬƂ
¼ŽòĀŦ-ƕƔťſŢťƎƋŸ)ťƒƀšŜŵŬŽś°ÙŽƃƀš¼ŽśòĀƁĖƀĖñƘ"żŊƍśŵŬťƒòĀŦ&ÑűƔťƘãġűƔŬžžůŷŜ

3. ƶƞƭǆƛƘ&ÑŮųƔªř ř ƶƞƭǆƛƃ¥Ǝ5ðƀòĀŽŠƔŜŋYŔ~ŃŽęaůżƎśŵƂ°ĲƃòĀSžòĀĄśòĀħť
ƒƀƓśơƴǀƏŵƂ

ƪǋƷƞħƎĺƘňšżƉžƙſòĀ%gMŦƌƒƕƀšŜ¢ƀŬžƘěţƄś

ƶƞƭǆƛƘŻƆůżÆ¾ƘÓůśĂħĿĄŽėźżůƋţƄśòĀžůż´āűƔƂŽƃƀšťž
šŢŬžŽŠƔŜƶƞƭǆƛƘŻƆůŷÆ¾ƁƃśÛ,ƋŽÑŧżšŷƶƞƭǆƛƂĖñ"żŦEƋƕżš
Ɣŷƍś°ÙƁĖñƘ"żŊƍƔĖŦƀšƂƎĻAŦššŜůťůƀŦƒśƶƞƭǆƛƂÆ¾ƘǆƽƩǌǀŽėźżƌżƎśŵŬťƒƶƞƭǆƛŦ&ÑűƔŬžƃƀšŜ"żƂĖñŦŠƔƁƎťťƗƒŲśƶƞƭǆ
ƛžůż&ÑůƀšƂƃƀŴť?ř þţżƌƕƄžżƎ5ðƀĠƀƂŸŦśÆ¾ƁƃÑŧżšŷƶƞƭǆ
ƛžºƈżśVŧŨ)ŪƔž2ŻƂÌŦWƗƕżšƔŜŻƃśƪǋƷƞħÇrƂÌŜŝƶƞƭǆƛƂ
òĀħƪǋƷƞÇrƃØmg/mlžƎšƗƕśōnƁŘÇrƂÄ¾ŽÂŷŮƕżšƔŜŬƕƘâáűƔžś
âáƂŷƍƂûē¾ƀſƘ0ţƔĖŦŠƔŷƍśŵƂÇrƃ10ťƒ1000çrƋŽůżůƋŢŜ
ƎŢŻƃśĄƪǋƷƞħƀſŦZMůżšƔòĀĄƂÌŽŠƔŜâáÆ¾ƁƃśòĀĄžĄƪǋƷ
ƞħƃZMűƔŦśŵƕƒƃ"żeĀƂƑŢƀxƁƀźżŤƓśƂƑŢƁƃ´āůƀšŜƋŷśÆ¾ƘĂ
ħĿĄŽėźŷžůżƎśĂħĿĄƁĄƪǋƷƞħƃZMůƀšŜŬƂƑŢƁś2ŻƂÌŦWƗƕżšƔŷƍśŝƂƶƞƭǆƛƁƕƀšƂŽƃƀšťžþţŷŜ
ř ř 4. ƶƞƭǆƛžƾƜƞǉƮƶƜƦƘĐAŮųƔř ř ŬƕƒƂÌƘŹŻŻśƶƞƭǆƛƘâáűƔŬžŦ
ŽŧƕƄśŵŬťƒƶƞƭǆƛƃ&ÑűƔƂŸƖŢť?ř ŬƂJœƘƞǆƛűƔŷƍśŝƃƾƜƞǉƮƶƜƦƘ+Óůŷ^ŗïƘþ¬ůŷŜƋŲśÇrƂÀfƁŇůżƃśƶ
ƞƭǆƛƘâáűƔŉƁśōnƁeŮšéƂ!ƕËƘ
ÓűƕƄÇrƂÀfƘţƔŬžŦŽŧƔŜŷžţƄś
ƶƞƭǆƛƂéžBŰũƒšƂ!ƕËƘ+ÓűƕƄśŵ
ƂmľÎƃ¥VŽ2ŽŠƔŜƶƞƭǆƛƂéƑƓƎeŮ
š!ƕËŽŠƕƄśŮƒƁmľÎƘţƔŬžŦŽŧƔŜ
ƋŷśĄƂÌƘøűƔŷƍƁśƶƞƭǆƛƂòĀĄž
kƂĂħĄƘĐAŮųƔŬžŽĄƪǋƷƞħƘźŷĂħĿĄƘűƔŬžŦ=āžƀƔŜŬƕƒƂ^ŗƘ

L 1ř Ǎ¹ǎ^ŗƁÓůŷƾƜƞǉƮƶƜƦ
ǍlǎįĵŜǍ?ǎď ĊñƘńŰŬƍŷ|śĂħĿĄŽėźżšƔŜƦƠǌǇƶǌƃ 5ŚmŜǍ¹ǎĂħĿĄŽėƗƕŷƫǃǋƶ
ǌƂƜǁǌƥŜ

^ÏűƔŷƍƁśL1ƁäűƑŢƀƾƜƞǉƫǃǋƶǌƘÓšŷŜŬƂƮƶƜƦƃśĵ8ƂàêƁŤšż~e¾ÅƘůśŵƂŽ1)YƂļñ;Ədigitalř ELISAŦ^ÏŽŧƔžPFŮƕżŤƓśÑËħžƎÜŦĉšŬžŦäŮƕżšƔ[2,3]ŜƋŷśŬƂƾƜƞǉƫǃǋƶǌƂ`ŁƃfLťƒ3fLžƶƞƭǆƛ

10ÑH2[àêǈƪǌř ř No.45 (2014 July)Ƃ`ŁžƎƉƊĆűƔŜŮƒƁŝƃśŬƂƾƜƞǉƫǃǋƶǌƁĂħĿĄƘűƔ¼ƎŅ×ů
ŷǍL1¹ǎ[4]ŜŻƋƓśŬƂƾƜƞǉƫǃǋƶǌƘÓšśƫǃǋƶǌĺ)ƁĂħĿĄƘůśƶƞƭǆ
ƛƂƻǉƯƻǅƦƯƘd!űƔŜűƔžśƶƞƭǆƛƂƻǉƯƻǅƦƯƃĂħĿĄžŨźŻŧśą×ÙƁĄĐAŦĩŧƔŜĄĐAŦĩŧƔžśƫǃǋƶǌ%ĺƁƃśƶƞƭǆƛ1)ƂòĀħ)"żŦd!Ůƕś
ĂħĿĄĺ)ƁƃǐĄƪǋƷƞħƂ"żŦd!ŮƕƔǍL2ǎŜŬƂƫǃǋƶǌƃśƶƞƭǆƛƂ"żƘźŷƫǃǋƶǌžƀƓśťŻśƪǋƷƞħÇrƂƎţƒƕśòĀĄƂÌƎøůżšƔŜŬƂƑŢ
ƀśƾƜƞǉƮƶƜƦžĐAůŷƵƜƺǆƬưƫǃǋƶǌòĀťƒśƶƞƭǆƛŦ&ÑűƔťƘ­ğűƔŜL3ƃ^ŉƂ^ŗŽ}ƒƕŷÕŽŠƔŜß7ŽäůŷGFPƘ×ÏůżšƔVăčƻǉƯƻǅƦƯǍaǎŦ3)|ƁƫǃǋƶǌƂxƁGFPƂď

ŦqŦƓśůżďŦÉŨƀƒƀšŬžŦƗťƔǍǏǎŜŬƂŬžťƒśĂ

ħĿĄŦuƒƕŷƫǃǋƶǌƁśVăčƻǉƯƻǅƦƯŦĐAůżšƔŬžŦƗťƔŜŻƋƓśŬƂƫǃǋ
ƶǌƃśVăčƂ"żƘźżšƔƫǃǋƶǌžƀƔŜ

ř 5. ƫǃǋƶǌĐAòĀƂƪǋƷƞħAř ř ƫǃǋƶǌĐAòĀƂ+ÈƂŻžůżśƫǃǋƶǌ
%¾Ɓ2AËƏDNAìƘŠƒťŰƍ0ţżŤŨŬžŽś
ĐA|ƁŵƕƒŦſƂƑŢƀyŐƘ:ƊűťģƈƒƕƔž
šŢŬžŦŠƔŜŵŬŽśƫǃǋƶǌƁATPǍƛƮƴƤǋ

L 2ř ƶƞƭǆƛžƾƜƞǉƮƶƜƦƂĐA³sLǆǋĽǎƘŠƒťŰƍ0ţżŤŧśƪǋƷƞAƁbűƔŵƂyŐƘģƈŷŜ$ÙƁƃśƫǃǋƶǌĐAòĀƃś
GFPƘ×ÏůżšƔŷƍśŵƂď

T2Ƙô¡ÙƁģƈ

ŷŜL4ƁäűƑŢƁś@ƫǃǋƶǌƂď

vrƃƫǃǋ

ƶǌņŽ±ŝƁT2űƔŜŵŬŽś^ŗŅXťƒ2¡ņ÷ŨT2ƁƂƌÞÚůŷŜŵƂT2ůŷĺ)Ƃď
vrT2ƂŧƘƻǉƬƯůŷƎƂŦL5ŽŠƔŜƶƬƹƚ
ǌƂƌƂƫǃǋƶǌƁĐAŮųŷQAśGFPď

vrT

2ƂŧƃoOůżƾƜƱƦŽŠƔŜŬƕƃśď

vrŦ

L 3 #ÊÈŔ~ŃŽƂƶƞƭǆƛžƾƜƞǉƮ
ƶƜƦƂĐAǍaǎĐA,ŜǍǏǎĐA|ÀfůżšƔŬžƘGůżšƔŜžŬƖŦśƫǃǋƶǌ%Ɓ 5mM ATPƘ0ţƔžśŵƂCŧŦƻǅƦƁīŰƔƎ
ƂŦUŨƀƔŜŵƂõ«śoOƃƻǅƦƂžƀźŷŜ
ŻƋƓśATPƘƫǃǋƶǌ%ƁŠƒťŰƍ0ţƔŬžƁƑź
żśƫǃǋƶǌĐAòĀƂƪǋƷƞħAāŦR0ůŷŬžƘäůżšƔŜ

KƂ^ŗŽƃśATPƂƌƘ­ğůŷŦśƛƿƴĽƏśŵƂ

ƪǋƷƞAƁŇƗƔ2AËƁŇůżƎ­ğűƔĖŦŠƔƂŽƃƀšťžþţƒƕƔŜµƁśƫǃǋƶǌƁDNAƘd!ůśŵƂDNAťƒƂGFP×
ÏƘģƈŷŜŵƂõ«ƘL6ƁäűŜ^ŗƃśƫǃǋƶǌ
%ƁŠƒťŰƍGFPƘƢǌưůŷƻǅƦƿưƘd!ůśGFP
Ƙ×ÏůżšƀšVăčƻǉƯƻǅƦƯƘĐAŮųŷŜĐ
A|śƻǅƦƿưťƒƂGFP×ÏƘď

ŽǂƲƪǌůŷŜ

11

L 4ř ƫǃǋƶǌĐAòĀƂ GFP ď vrT2
ƸǋƞśĨśČƃŵƕŶƕƫǃǋƶǌĐAòĀ 1ŻƘĔűŜúžŌƂǅƜǋƃĐAůżšƀšƫǃ
ǋƶǌƂď vrT2Ŝ

ÑH2[àêǈƪǌř ř No.45 (2014 July)
űƔžś3¡ņƁƗŷźżśGFPƂď

ŦęaŮƕƔƫǃǋƶǌŦƌƒƕŷŜŽśƋźŷŨď

vr

ŦT2ůƀšƫǃǋƶǌƎãġŮƕżšƔǍBackgroundǎŜŬƕƃśƫǃǋƶǌĐAòĀ%Žśƫǃǋƶǌ
%Ɓd!ŮƕŷƻǅƦƿưťƒGFPŦ×ÏůżšƔŬžƘäůżšƔŜŻƋƓƫǃǋƶǌĐAòĀƁŤšżƎś
DNAťƒƪǋƷƞħƇƂī'ýĞžšŢƨǋƯǅǇưƟƾŦ´āůżšƔŬžƘäůżšƔŜŬƕƒƂŬžƑƓś
VăčƻǉƯƻǅƦƯžƫǃǋƶǌƘĐAŮųŷśƫǃǋƶ
ǌĐAòĀžƀźżƎƪǋƷƞħAƘö÷ÙƁđšś
DNAťƒƂī'ýĞƎ=āŽŠƔŬžťƒśƫǃǋƶǌ%ĺƂƪǋƷƞħAïƏĤïžšźŷÑHƤƦƭǀƃ´āůŢƔÌƁŠƔŬžŦäIŮƕƔŜ
ř 6. ƫǃǋƶǌĐAòĀťƒVăčƃ&ÑűƔť?
ř ř ŬƕƋŽƂ^ŗƁŤšżśVăčžƫǃǋƶǌƂĐA
ƏśƫǃǋƶǌĐAòĀƂƪǋƷƞħAƁŇůżPF
ůŷŜŬƕƒƂ^ŗƘđźżšƔžśōnƁmŽƃŠƔŦś
ƫǃǋƶǌòĀťƒ(ċűƔƑŢƀÏĥŦƌƒƕŷŜŵƂ
ĳ÷'ÝƘL7ƁäűŜŬƂƑŢƁśƫǃǋƶǌĐAòĀ

L 5ř @ƫǃǋƶǌĐAòĀƂď

vrT2

ťƒǆƽƩǌǀ±ƂƎƂŦŖƅ(żŨƔƑŢƁƌţƔŜůť
ůƀŦƒśŬƂ(żŧŷťƘK<űƔ¼ŦÏÌŽƃƀ
šŷƍśŬƕŦ)ĕůR¸űƔƂťśVăčƂơƴǀƘ
źżšƔƂťƀſ­ğƃŽŧżšƀšŜŵƂŷƍśŬƂ
ÏĥŦƶƞƭǆƛƂ&ÑƘäůżšƔƂťƃƗťƒƀšŦś
ōnƁćG¿šÏĥŽŠƔŬžƁĶšƃƀšŜ
ř 7. ŤƗƓƁř ř ƶƞƭǆƛƂ&°ƘÚůżśƶƞƭǆƛžƾƜƞǉƮ
ƶƜƦƘĐAŮųƔ¼ƁŇůżšƖšƖ­ĝƘđźżŧ

L 6ř ƻǅƦƿưƘd!ůŷƫǃǋƶǌ%ŽƂ
GFP ×ÏƁƑƔď vrT2ř
@ǅƜǋƃŻƂƫǃǋƶǌƘÏűŜ

ŷŜƋŸƋŸ×iİƂàêŽŠƓśŻŷƀšĺ)ƎUŝ
ŠƔŜůťůƀŦƒśōnƁćG¿šÏĥƎƌţżŧżŤ
Ɠś|Ƃ×iƁŭ§{ŕšŷšŜwŎƃśŖƅ(żŧŷťƘëŧ¶ƍƔ^ŗƘĴƍżšŧŷšžźżšƔŜř ĤĬř ř ©àêƃæ[Ēć´°ŮŧŦŪàêƁƑźż^ŮƕŷŜƋŷśƫǃǋƶǌƁĂħĿĄƘuƔĒƁŇůżƃBŰàê_ƂÁĹ.1ƂŅ×ůŷĒƘÓšżšƔŜŀN6đťƒƃśàê"ĈƁƗŷźżś
±ŝƀ1ěƘőšŷŜŬƂQƘƓżŤåÔůūƋűŜ12

L 7ř ƫǃǋƶǌĐAòĀťƒƂ(ċß7ƃƫǃǋƶǌĐAòĀťƒ(ċůżŧŷƎ
ƂƘäűŜÑH2[àêǈƪǌř ř No.45 (2014 July)ř 9þÍ
[1] D.G. Gibson, J.I. Glass, C. Lartigue, V.N. Noskov, R.Y. Chuang, M.A. Algire, G.A. Benders, M.G.
Montague, L. Ma, M.M. Moodie, C. Merryman, S. Vashee, R. Krishnakumar, N. Assad-Garcia, C.
Andrews-Pfannkoch, E.A. Denisova, L. Young, Z.Q. Qi, T.H. Segall-Shapiro, C.H. Calvey, P.P. Parmar,
C.A. Hutchison, 3rd, H.O. Smith, J.C. Venter, Creation of a bacterial cell controlled by a chemicallysynthesized genome, Science, 329 (2010) 52-56.
[2] S. Sakakihara, S. Araki, R. Iino, H. Noji, A single-molecule enzymatic assay in a directly accessible
femtoliter droplet array, Lab on a Chip, 10 (2010) 3355-3362.
[3] S.H. Kim, S. Iwai, S. Araki, S. Sakakihara, R. Iino, H. Noji, Large-scale femtoliter droplet array for
digital counting of single biomolecules, Lab on a Chip, 12 (2012) 4986-4991.
[4] R. Watanabe, D. Fujita, K.V. Tabata, L. Yamauchi, N. Soga, S.H. Kim, H. Suga, H. Noji, Highthroughput formation of sub-million lipid membrane arrays for measuring membrane protein activities,
proceedings of MicroTAS 2013, (2013) 1314-1316.

13ÙK5aêöǑƯǕŜ Ŝ No.45 (2014 July)¶FŜ ºśŜ ŌǖŬƗųŮŜ ƓůǗļ^a^aŊpaêöòŚ)_5ajŜ §9ZĨôǘu
kawasaki.riku.47n@st.kyoto-u.ac.jpŲƅwƆŢÙK5aêöǑƯǕť·ƄƃŽŻĩŦƉƅSùƅ²ƘŪſŨŻżŮŢÃůĪÝŴűƊŶţðƆ¢uŢ2014u3¥Ɗƀ^ňrø^aǔńśŜ ƄlŨŻżŮŢ2014u4¥ƑƓŢļ^aǔñDŜ ƄlŨŻżŨſūƓƊŶţdŴůūŗŨÝŴűƊŶţÕRƆƶƸƤǐƘÛŨŻŢá¸5]ÿŬƒƃƔƶƸƤǐƁÎ²5CÑƘăƋCƗŸŻƶƸƤǐşÎ²ƹƜǀǏƱƵƄŇŶƔêöƄƗƒŸſŨŻżŨſūƓƊŶţ
ǊǏƚƄŇŶƔĩƘǙUĂNƆƜǈǕƪǓƣ²ČƘ¦ŶƔ»ãĔ>ƈƵǎƱƣƳǏƺǏǕƩƫƲǇÛơ
ųŸſŨŻżŮƊŶţŜ

Ŝ
Near-infrared dye loaded polymeric nanoparticles for cancer imaging and therapy and cellularresponse after laser-induced heating
T. Lei, A. F. Fernandez, R. Manchanda, Y. -C. Hung, and A. J. McGoron, Beilstein J. Nanotechnol. 2014, 5,
313-322.
ĴuŢŭƙ»ãƘçåƁŴŻƜǈǕƪǓƣ²ČƘ¦ŶƔƭǎƸƫƲƱƢƶƸƳƺƜƫƄŇŶƔêöŭķƍƒ
ƕſŨƊŶţƃŬƀƎŢƶƸý_ŭĖÈßƄƕſŨƔŲƁƏƶƸý_$ĻƄĔ-Ƙi!ŶƔŲ
ƁŭŭƙāċƅĔ-ĊƄhŴſ¦4ƀŧƔŲƁŭUIųƕſŨƊŶţƊŻŢčâJĲĻƅĖûĵĸŭĒŴůķŴſŨƔŲƁŬƒŢý_~ŭ 100 nm ƄþgƄ+ųƕŻƶƸý_ŭčâĻƉŏõŴƏ
ŶůŢ1ŪſčâĻƅǏǓƻĀŭäĹŴſŨƃŨŲƁŬƒŢčâĻƄŏõŴŻÑīŭ\ĻƉ¼ųƕŷēõŴƏŶŨƁŨũ EPR 4¬ŭUIųƕſ«ŢƳǓƵǏǅǕƃƂƅŚ)_©Ƙ*ÛŴŻƶƸý_ƄŇŶƔêöŭķƍƒƕſŨƊŶţƊŻĕ

Ķ}½Ɔ MRI Ə PET ƃƂƅ«ƅƜǈǕƪǓƣĘƁµıŴſŢŚĢwƀŧƔÍƏµıåbƄe¡ŶƔŲƁŭƀŮƔÍƃƂ°Ťƃ*ÍƘ¦ŴſŨƊŶţƃŬƀƎŢĴ
Ĭ\

ǖ700-900 nmǗƆÙ$ƄūŨſH@ƘƎž5CÑŭ`RŴſŨƃŨŲƁŬƒŢĴĬ\ƁŶƔ5CÑƆÙ$ƜǈǕƪǓƣƘėũũŪƀ¦ÛƀŧƔƁųƕſŨƊŶţĴĬ\ÑƁŴſŢƜǓƵƩƚƷǓƣǏǕǓǖICGǗŭ¿çųƕſŨƊŶţŲƅ ICG ƆĴĬ\

Ƙ3ĭ

Ƙ3ĭ
ƄƎž5C

ƘH@ŴŻōƄĕ

äŶƔ\ƄƎŢÐƘäÙŶƔŲƁŭéƒƕſŨƔŻƍŢŭƙÆÐã½ǖƹƜƻǕƧǕǆƚǗƉƅ
ųƕſŨƊŶţŴŬŴƃŭƒŢŲƅ ICG ƆĖÉƄūŰƔbcƄŴůŢŹƅ

ƘÛŭ§ÛüOƆ+ŉųƕſŨ

ƊŴŻţŜ «ŢƹƜƻǕƧǕǆƚƆĎvƄūŨſŢŭƙ-ƘÛŨŻ5aã½Əkąã½ƅĘƄū
ŰƔě2ã½ƁŴſÛŨƒƕſŮƊŴŻţŴŬŴƃŭƒŢŲƅƹƜƻǕƧǕǆƚƘ¡ŶŲƁƄƑŽſŢHIF-1 ŭĸ/äÕŶƔBČŭîLųƕſŨƊŶţHIF-1 ƁƆŭƙāċƄūŨſŢįóƏÁÊƄŇŶƔƯǓƻƢī
ƅį%ƘķŶƔŻƍŢŲƅ HIF-1 ŭĸ/äÕŶƔŲƁƄƑŽſŢ»ã4¬ƅŭ;ųƕſŨƊŶţ
ƹƜƻǕƧǕǆƚƄƑƓŢHIF-1 ƅäÕŭķųƕƔǈƠƷƬǇƄƆƼǕƴƩǍƱƢǁǒƲƜǓǖHSPǗŭŇŴſŨƔƁŨƗƕſŨƊŶţŲŲƀùĉƒƆŢƹƜƻǕƧǕǆƚƄƑƔ HSP äÕŁƆ1Æ£ņƅńųƄ`ŴſūƓŢICG ƘÛŨƔŲƁƀǑǕƨǕÏkƄhŴſŢ<£åƃ1ÆŭėŪƔŲƁŬƒŢHSP äÕ+ƄūŨ14ÙK5aêöǑƯǕŜ Ŝ No.45 (2014 July)ſ¦*ƄƆŻƒůŲƁƘğ(ŴſŨƊŶţŜ
ùĉƒƆƣǏƭǒǕǐŢǏǓƦľŹŴſƵƳƠǓƪƟǕǐŬƒƃƔǄǏǅǕǖPGMDǗƘCŴŢICG ŘĆƀŧƔ IR820 ƘřŴŻ IR820-PGMD ƶƸý_ƅƜǈǕƪǓƣČūƑƈŢƹƜƻǕƧǕǆƚƄūŰƔ²ČĥƘėŨƊŴŻţPGMD Ƅ IR-820 ƘřŶƔŲƁƄƑŽſāċǔÙ$ƀƅƜǈǕƪǓƣƘėŪƔżŰ
ƀƃůŢIR820 8ÓƀÛŨŻVCƁµıŴſŢIR820-PGDM ƆŢ24 £ņƄūŨſƎ{ŨĕƘîŶŲƁƘìĦŴſŨƊŶǖFigure 1ǗţųƒƄ IR820-PGMD Ƙ MES-SA/Dx5 āċƄhŴſŢ¤őŴŢǑǕƨǕŧ
ƔŨƆƜǓơǋǂǕƯǕƘÛŨſŢ

ÏkŶƔŲƁƄƑŽſŢƃ´āċ4¬ƘƔżŰƀƃůŢROS ÚÙŢVEGF äÕŢŹŴſŢHIF-1 ÀƘƄ+ŶƔŲƁƘğ(ŴſŨƊŶţŜ
ŲƅƑũƄ IR820-PMGD ƄƑƓ«ƅ ICG ƅŪſŨŻbcƅMŖÍƄ1ŪŢǑǕƨǕƘ
ÛŨŻƹƜƻǕƧǕǆƚƅŪſŨŻ HIF-1 äÕƅMŖÍƅ?

ƘĢ¹ŶƔŲƁƄ0ŴſŨƔŲƁŬƒŢŲƅ IR820-PMGD ƆƜǈǕƪǓƣČ
Ƙ¦ŶƔ»ãĔƁŴſŢ§ŶƔŲƁŭƀŮƔƅ
ƀƆƃŨƀŴƐũŬţŜ Ŝ Ŝ Ŝ Ŝ Ŝ Ŝ Ŝ Ŝ Ŝ Ŝ Ŝ Ŝ Ŝ Ŝ Ŝ Ŝ Ŝ ŜFigure 1 IR820 ƅÙ$ƜǈǕƪǓƣǖĩƑƓyÛǗŜ
ŜSuperparamagnetic hollow hybrid nanogels as a potential guidable vehicle system of stimuli-mediatedMR imaging and multiple cancer therapeutics
W. -H. Chiang, V. -T. Ho, H. -H. Chen, W. -C. Huang, Y. -F. Huang, S. -C. Ling, C. -S. Chern, and H. -C,
Chiu, Langmuir 2013, 29, 6434-6443.
ŜŚ)_5CÑƅďqăć5ƆƵǎƱƣƳǏƺǏǕƩƫƲǇǖDDSǗƅơǊǏƚƏƶƸƧƜƬƅƺƜƟǏƚƢƯ
ǕƘĤģŶƔũŪƀŒtƄ¦Ûƃ³ƁŴſÛŨƒƕſŮƊŴŻţƃŬƀƎŢ6ãƅ)ŀƉƅÛƆçġƊŴůŢƃŬƀƎ MRI ƅĶ}-ƁŴſ{íƘ¦ŶƔľ5ŃǖSPIONsǗƘǏǄƮǕǇƏǆƭǐŹŴſƶƸƤǐ
ƃƂƅ$ĻƄi!ŴŻŭ]ůUIųƕſŨƊŶţƊŻ SPIONs ƅƎžíƘ*ÛŴŻĻƉƅnåƃƳǏƺǏǕŢŹŴſŢŭƙÆÐã½ǖƹƜƻǕƧǕǆƚǗƉƅ

ÛƃƂ°Ťƃ

ÛŭUIųƕſŨƊŶţŲ

ƕƒƅČƆ"ſľ5Ńƅi!ÔƄƑŽſ¹cŴƊŶţŜ
ùĉƒƆƢƞǓľƀĚĞŴŻ SPIONs Ɓ ŞŝǈƯƢǏǒƜǐƞưǐƚƢǏǑǕƴǖMESǗƁǄǏƞưǑǓƣǏƥǕ
ǐǖPEGǗƘƣǎƿƴ5ŴŻǄǏƚƢǏǐľǖPAAǗƁǄǏƜƮǁǒƾǐƚƢǏǐƚǆƵǖPNIPAǗ#ĿCƘĝC5ŶƔŲƁƄƑŽſŢ÷ÒƅƶƸƤǐƘĜŴƊŴŻǖFigure 2ǗţŲƅƹƜǀǏƱƵƶƸƤǐƆ MES ƘƞƫƲǐĄCƄƑƓ¯ĶƘbc5ŴſŨƊŶţŲƅ

ŴŻ½ƄƑŽſŢÙ× pH ªƀý_~ 190 nm ôwŢęœŐđŭ-18.5 mV ƅÖÒƅƹƜǀǏƱƵƶƸƤǐŭƒƕƊŴŻţŲƅƹƜǀǏƱƵƶƸƤǐƆl!ŴŻ
SPIONs ƄƑŽſŢŚJ¾ƅíÞƄūŨſŢƹƜƻǕƧǕǆƚƄƑƓäÐŶƔŲƁƘìĦŴſŨƊŶţƊ
ŻŢpH ƏÆwƃƂƅ\Ļ,ËƄúŶƔŲƁƀ$ĻƄi!ŴŻƵơƮǐƽƩǓǖDOXǗƃƂƅĔ-ƘƹƜǀǏƱƵƶƸƤǐ\ĻƉƁ(ŶƔŲƁƘìĦŴſŨƊŶţųƒƄŢŲƅƹƜǀǏƱƵƶƸƤǐƘÛŨŻ T2-type ƅ
MRI ƘėũŲƁƄƑŽſŢÙ× pH ªƄūŨſŢƑŨƥǓƴǎƫƴƜǈǕƪƘƔŲƁŭƀŮŻŻƍŢŚŨ
MRI Ķ}ČƘƎžŲƁƘìĦŴƊŴŻǖFigure 2ǗţŲƕƘ*ÛŴſāċJĲĻƅmØXŭzľƄ
15ÙK5aêöǑƯǕŜ Ŝ No.45 (2014 July)ŨſŨƔčâăćƄūŨſ in vivo ƜǈǕƪǓƣŭBČƀŧƔƁĈŪƒƕƊŶţƊŻƹƜǀǏƱƵƶƸƤǐƘā
ċ$ƄAĳƊŸŻÒƀ MRI ƄƑƓƜǈǕƪǓƣŶƔŲƁƄ0ŴſŨƊŶţ

NŢƹƜǀǏƱƵƶƸƤǐƘ

HeLa āċƄ¤őŴŢŹƅŢ\ĻŬƒíVƘ:1ŴŢƹƜǀǏƱƵƶƸƤǐƘāċJĲĻƉƁħlŴŻƁŲ
ƖŢíVƄƑƓħlŴƃŬŽŻVCƁµıŴſŢƅāċ$ƉƅAĳƋŭìĦųƕƊŴŻţŹƕżŰƀ
ƃůŢSPIONs ƅƹƜƻǕƧǕǆƚƁ DOX ƅÛƄƑƓŢƹƜƻǕƧǕǆƚŢDOX Źƕźƕ8ÓƅVCƁµıŴſŢHeLa āċƄhŶƔāċŎfŭY{ŶƔŲƁƘìĦŴƊŴŻţŜ

Ŝ
Figure 2 ƶƸƤǐƅ±xP>ƈŹƅĶ}²ČǖĩƘĻ[ǗŜŜŜNŢùĉƒƅĜŴŻ÷ÒƹƜǀǏƱƵƶƸƤǐƆ$ĻƄĔ-Ƙi!ŶƔŲƁŭƀŮŢpH ƏÆwƁŨŽŻ\Ļ,ËƄ

úŴſĔ-Ƙ(ŶƔŲƁƘğ(ŴƊŴŻţŹƕżŰƀƃůŢƶƸƤǐ|£Ƅl!Ŵ

Ż SPIONs ƄƑƔŢƹƜƻǕƧǕǆƚŢMRI Ķ}²ČƘìĦŴƊŴŻţŲƅƑũƄ

NĜŴŻƹƜǀǏƱƵƶ

ƸƤǐƆƹƜƻǕƧǕǆƚƁ5aã½ƅÛŭBČƃĠƭǎƸƫƲƱƢƶƸƳƺƜƫƁŴſƅ

Ûŭ§ųƕƊŶţŜ
SiO2@YBO3: Eu3+ hollow mesoporous spheres for drug delivery vehicle
G. Yang, S. Gai, F. Qu, and P. Yang, ACS Appl. Mater. Interfaces 2013, 5, 5788-5796
Ŝ ĴuŢŚ4ÔŬž.ÛƘİÅŶƔŲƁŭBČƃƵǎƱƣƳǏƺǏǕƩƫƲǇǖDDSǗƅêöŭæƙƄķƍ
ƒƕſŮƊŴŻţŪƇŢŹƅŚŨÙĺCŢŚŨÙ)ĢŹŴſơǊǏƚęœƅǄƚƘ+ŶƔŲƁŭ
ƀŮƔǈƮǄǕǎƫƩǏƠƘTƁŴŻDDSơǊǏƚƅŅäŭ¿çƘŏƍſŨƊŶţǈƮǄǕǎƫƩǏƠƆƩǏ
ƠęœƄ²ČƘƀŮƔŲƁŭƀŮƔŻƍŢDDSƄƑƔ»ãƅƋƃƒŷŢE£ƄƜǈǕƪǓǓƣƘėũŲ

ƁŭƀŮƔƭǎƸƫƲƱƢƶƸƳƺƜƫƁŴſ§ųƕſŨƊŶţƊŻŢƜƱƴǏƝǇƏǌǕǒƾƝǇƃƂƅsQ
ŘłoƆŚŨĕ

²ČƘ¦ŴſŨƔŻƍŢ­Đ©ƁŴſ§ųƕſŨƊŶţ
16ÙK5aêöǑƯǕŜ Ŝ No.45 (2014 July)Ŝ ùĉƒƆľ5ŃƘƲǓǁǑǕƴƁŴŻǈƮǄǕǎƫƩǏƠƘCŴŢƲǓǁǑǕƴƁŴŻľ5ŃƘľ'×ƄƑŽſŋ=ŴŢ÷ƅǈƮǄǕǎƫƩǏƠƘCŴƊŴŻţƩǏƠęœƄǌǕǒƾƝǇƘƵǕǁųŸŻǃƝľƜ
ƱƴǏƝǇƘřŶƔŲƁƀDDSÛĠƶƸơǊǏƚǖFigure 3ǗƘCŴŢŹƅ²ČĥƘėŽſŨƊŶţ

Figure 3Ŝ ĠǈƮǄǕǎƫDDSơǊǏƚĤģƅ®àPŜ ƊŷŢW5Ń(š)ƁĽľƶƴǏƝǇƘƞưǑǓƣǏƥǕǐƁƞưǑǓƪƚǆǓÇÂƄÇĢųŸŢ200ŠƄ1
ÆŴŢ&ŶƔŲƁƄƑŽſŢƲǓǁǑǕƴƁŶƔý_~90 nmôwƅľ5ŃƘCŴƊŴŻţŲƅ

ƄƎý

_~180Ţ300 nmƅľ5ŃƘCŴŢƲǓǁǑǕƴƁŴſÛŨƊŴŻţŲŲƀƒƕŻľ5ŃƄhŴſŢWľ
'×ŹŴſĮŔ¾'×ƘėũŲƁƀľ5ŃƘ7))ųŸŢƚǓǉƷƚ¸ƘGƌƞƯƸǕǐŢƭưǐƴǏ
ǈưǐƚǓǉƷƝǇǀǒǅƜƵ`RŢTEOSƘÄ1ŶƔŲƁƀľ5ŃęœƄƩǏƠƘĚĞŴƊŴŻţŲŲƄ
ÌWľƘ'×ŶƔŲƁƄƑƓŢƩǏƠ$Ļƅľ5ŃƘÇ(ųŸƔŲƁƀ÷ÒƅƩǏƠƶƸý_ƘCŴƊŴŻţŲƅƩǏƠƅęœƄëľƜƱƴǏƝǇƁëľǌǕǒƾƝǇƘÛųŸƔŲƁƄƑƓŢƶƸơǊǏƚ
(HMSs@YBO3:Eu3+)ƘƊŴŻţHMSs@YBO3:Eu3+ƅ$ĻƄŭƙ-ƀŧƔDOXƘi!ŴƊŴŻţŲƅƁ
ŮPBSƄūŨſŢ30-40%Ƙ(ŴƊŴŻţŹƕżŰƀƃůŢý_~`åƄ(ŶƔŁƆY^ŶƔŲƁƘ
ìĦŴſŨƊŶţHMSs@YBO3:Eu3+ƅęœƁDOXƅņƄÙŵƔèÛżŰƀƃůŢ|ųƕŻ÷¯ĶƅƧƜƬƏęœƅǄƚƅƧƜƬƄƑŽſŢ(Ɔ+ųƕſŨƊŶţŹƕżŰƀƃůDOXƅǏǏǕƫƆÙ
×pHªƁµıŴſŢľªƄūŨſķųƕƔŻƍŢāċJĲĻƅmØXŭzľƄŨſŨƔčâăćƄūŨſ4ÔåƃDOXƅǏǏǕƫŭBČƀŧƔŻƍ.ÛƅÅƄ§ƀŮƊŶţǅƝƫ
ĄCăćÜ«ƅāċƀŧƔL929āċƄhŶƔHMSs@YBO3:Eu3+8ÓƅāċŎfƘMTTƚƱƭƜƄƑ
ƓĥŴŻƁŲƖŢ200 µg/mLƅÌwƊƀāċŎfƆìĦųƕƃŬŽŻŻƍŢDDSƄūŰƔơǊǏƚƃƂ
ƺƜƟǈƳƛƠǐ)ŀƉƅŜÛŭ§ƀŮƊŶţ

NŢùĉƒƅĜŴŻHMSs@YBO3:Eu3+ƆƲǓǁǑǕƴƁŴŻľ5Ńƅý_~ƄƑŽſŢŹƅ¯ĶƘ+ŶƔŲƁŭƀŮŢ÷ÒƅǈƮǄǕǎƫ¯ĶƘ¦ŶƔŲƁƄ1ŪŢä²ČƘƎžŻƍŢDDSÛĠơǊǏƚƁŴſ§ŶƔŲƁŭƀŮƊŶţŜ ¨ùƄƃƓƊŶŭŢ

NŢŲƅƑũƃ²ƘŪſŕŨŻ ^ňrø^a^aŊpaêöò 5aÙÑĀj ńśŜ   ƄÃůïÝŴűƊŶţ17

a$/lmøàü¦ ¦ No.45 (2014 July)má t¾Ř( 0-&řà­´¬øĸĐ´ČĒÏ þèġÆøĸ´ČĒŉ «Ĵđ 2 ¿uematsu@mail.tagen.tohoku.ac.jp
 #À$þ´ČĒgKkì"!ĵÙ&#¦Ĕ#èz5œÈ.0ÍĶām(ü¥ď$à­´¬øĸĐ´ČĒÏ ¡ĀÂ×Ó#+U9]?E7ŎŃĄË5çĈ1ãňĥōć5ĊÒu½ãň#Ī5Nk^"ČĒ"0ě6

0( ®÷ãňeiň§#ňę±5čŗ±"ĝÔ PS =eC"ē5ć2("q"ãňĥ#Éÿ5ĊÒ¬Ø#u½ãňŘŔãňřōć2(v¢$Ľ¿ĉ6"

ħ421ãňĥōć#üú"Ŏ1¨5 1 ¨/"9?b·Ì½T®¸¿ªQÁæõâØäöëöüDÀ·ÌMIÁH 2 +Ïuªº¶Å·¨

Antisense therapies for cardiovascular/metabolic diseases
R. S. Geary, R. Crooke, S. Bhanot, W. Singleton, Drug Discov. Today Ther. Strateg., 2014, in press. (DOI:
10.1016/j.ddstr.2013.06.001)¦ RNA ÏSh¾·ÌQÂG@û_c@¯¥±§/!BÀÉÌ,C¯ÀµÍÌÁ½0@¯¥ª¾ª«^¯©ËÅ·¨¹ÁºÆ§U}½©Ë§Åº§4L*¾¶¼8±lmµÍ¼­Ë§`)½Â RNase H È RNAi ÏZb¶ºCX¯olm¾¶¼ÎÍ¼ªÅ·¨´ÁH½Â§¹ÍÊÁ½ÇW¤VÅ½Ð»Ïu

¶¼­ËÅ·Á½§Fqªº¶Å·¨TM¦ MipomersenýKYNAMRO þÂÑðöðàúì× apoB-100 ÏSh¾¶ºQ½·¨Gap motifý' 1þ
¾#ÃÍÌs{@¾ RNase H Z@ÁnÏ

}¾·ÌRÏN¶§Phase 3 ¤À­ª¼¥ÚøÞãùü

÷dAzÄÁEÀÉËN¿WfP¯+"µÍ¼ªÅ·¨p(½%

Ï³§QÁ£³¾¶¼YiÏÆ¼ªÅ·¨¦ RNAi Ïb¶ºQ½Â ALN-PCS ¯ Phase 1 ¤Ï1
·Ì PCSK9 ÏSh¾¶§PCSK9 g`Ï3·Ì´¾½ LDL ÚøÞãùü÷]:À

Base
O
HO

B¶¼ªÅ·¨¶¼ªÅ·¨ALN-PCS Â LDL 4Ï

Base
R
O
O P
O
S

O

Base

Base
R
O
O P
S

O
O
n

O
O P
S

O
O
n

Base
R
O
O P
O
S
n

O

R
OH
R=

O

O

' 1. Gap motif

wª¼§QÁæõâØäöëöüDÀ·ÌMIÁH 2 +Ïuµ¸¼¢°Å·¨

Ultrasmall gold nanoparticles as carriers for nucleus-based gene therapy due to size-dependent nuclear entry

S. Huo, S. Jin, X. Ma, X. Xue, K. Yang, A. Kumar, P. C. Wang, J. Zhang, Z. Hu, X. -J. Liang, ACS Nano,
2014, 5852-5862.
¦ Triplex-forming oligonucleotidesýTFOsþÂ_2Á DNA ¾Ï;B¶§-g`Ï3·Ì¾kÊÍ¼ªÅ·¨¶®¶¿¯Ê§TFO ÂSh DNA ¯.)·Ìt|QÀ·ÌÀ§t|½ DNase ÀÉËµÍ¼¶Å«Á½§¹Át|øï÷ÄÁ?bÂ&½·¨¹´½zÊÂ§ÚúÝóÙüÜôúÀÉËÖ

öÛé×øÖáæÁ02@Ï¥ÆÏ²´¾¯+"µÍ¼ªÌçêr-ýAu-NPsþÀji¶Å¶º¨18

a$/lmøàü¦ ¦ No.45 (2014 July)¦ zÊÂJÀ§50 nm Áçêr-¯§~et|À\±[·Ì´¾Ï¶§+"¶¼ªÅ·¯§t|Q5ÂOB½¶º¨r<Á>6ÀÉË§r-¾ÚúÝóÙüå¶º TFO Át|Q5¯}À¿Ì¾y¬§Tiopronin ĨŒŔŋRTĖ±5}Ī(ŘAu-TIOP NPsřrŁ0#ÛïĖÃ 2
nm6 nmŘ£ 2 ařĖÃ 10 nm16 nmŘ£ 2 bř5}0(/"ĚĠĸjĚĠĢ¸Į#*"ĨŒ5 FITC Ħçķø+Î( ¶ŏ" MCF-7 ĚĠ&#¸5äĲĜâ2#ĖÃ5Þ1ŋRTĖ±+ĚĠĸ&#¸İõ2ù" 2 nm Au-FITC NP $ĚĠã&#¸+İõ2(Ř£ 3řĤğ/$ãĢġ!Ç¹Ė±ŘĖÃ 9 nm ynř#)²ī|".1ãĢ&#ĻĿĞ

ãĢ5ŀŅĜâ(é"ãĢŀŅġ1Ý/

! 2 nm Au-TIOP NP " c-myc Ň{±5çĈ1

POY2T x TFO 522BiFbAkP(ŘAu-POY2T NPs, £ 2cřAu-POY2T NPs
5 MCCF-7 ĚĠ+" 24 h 9i?b[kEciÅ# c-myc Ň{±ćüŊ5e7fK9_ PCR.%:;GKiYhMN8i@ľĺ3TFOŘPOT2TřûóĘ$ 80 % đÀ(Ñ2!

#"·Au-POY2T NPs óĘ$ 20%đÀ(­



ćüŊ



İõ2(Ř£ 3ř2/#¶ŕĜâ$ŋRTĖ±!ćüŊÑ

TFO "ãĢŀŅÊ5xo/"#ŀŅÊ$ĖÃ"~³åÇ¹Ř2 nmř#ŋRTĖ±5ÿ1ã#çĈŇ{±#ćü5ÑĞ
(a)15Ď(ĚĠã&ĥ5ĻĿ1îÿÊ#ŖÚĭ#Ðï#l/2vÅ#»ō

ßÄ2(
(c)(b)' 2. (a) Au-NPs  Xýr< 2, 6 nmþ; (b) Au-NPs BXýr< 10, 16 nmþ(c) Au-POY2T 
American Chemical Societyþ

' 3. A 2 nm, B 6 nm, C 10 nm, D 16 nm Au-FITC NPs 7)ÓñüÝúØ; x:
Au-FITC NPs; ¡: MCF-7 t|QýCopyright 2014 American Chemical Societyþ

19XýCopyright 2014

' 4. ÔÕÞàúîùâãÒúØvP
(Copyright 2014 American Chemical Society)a$/lmøàü¦ ¦ No.45 (2014 July)
Versatile RNA interference nanoplatform for systemic delivery of RNAs
K. Y. Choi, O. F. Silvestre, X. Huang, K. H. Min, G. P. Howard, N. Hida, A. J. Jin, N. Carvajal, S. W. Lee, J.
-I. Hong, X. Chen, ACS Nano, 2014, 8 (5), 4559-4570.
 ĆĚĠ5çĈëÊ#! RNA OeVekEGN_#ōć

RNAi ąï#ŉėĈ"ħ

42(RNAi #Ō!1 siRNA , miRNA #ĚĠ¸#*"2("¬Ø# RNA O
eVekEGN_ōć2(Ĥğ/$îÿÊŖ µ5Ŗ* RNA OeVekEGN_#æĕ"Úĭ RNA RT?ae7#ōć"0ě6( #RT?ae7$įíĈ!W7fhiňăíĈ! 5β-Bdiň5BiFbAkPpį°
Êæł5B7"(ŘHA-NPřĆĚĠĨŒ"$W7fhiňgHZKk1 CD44ćü1ċ/2Ņ

0CD44 5w<iQD9PkEG".1ĆĚĠùĂĈĚĠ¸ßÄ2(/"eiň7S=iĜ1

ċ/21 Zn(II)-dipicolylamine

ŘDPA/Znř5ŃĜHA-NP " RNA ĜŚńÕèġ5xo(ŘHDz/RNAř(($þ|#eiň7S=i#sÔ".0çĈņ" RNA#ıŐ(ġÊŖ#HDz/RNA ĨŒ5eiň>fE:_ŘCaPřĩĬ(ŘCaP-HDz/RNA£ 5řCaP-HDz/RNA<iQD9PkEG".0ĚĠ"0ļ(21Åß<iQJk_#ňÊý

©".0CaP ĩĬöıöeiň9=i(CaP #öı<iQJk_#9=iÁÀRNA , HA-NP B7¬$Áêőģ5ÞmÜñŀ¤".0<iQJk_

ĚĠĸ"Ö2ĥ#ćü0ĚĠëÊ+º!

kI".0ı21#ĚĠëÊ$'6$îÿÊ

DPA/Zn m# RNA sÔ RNA

ıŐ
¼ª1

ßÄ2(Ň{±¸EGN_#/)/2(HA-NP B7$W7fhSL

Ď(6#ŖĆĚĠ"·âĈ! RNA RT?ae71Ğ/CaP-HDz/RNA/2( /"Ĥğ/$^:G5ÿ in vivo #ĚĠ¸èġsiRNA ".1 RNAi #äĲ5ħ(\KffEX;dkIŘfLucř5ćü1ĆĚĠ#ò¯
5`SKei@ĳ

HA-NP

DPA/ZnDrug(Optional)

RNA

CaP

3  siLuc 5 ð    ^ : G' 5. CaP-HDz/RNA BX (Copyright 2014 American Chemical Society)Ř Control:

(a)

PBS,

Non-cording

sequence: siNCř"#)

fLuc ćüŊ#Ĉ!ôº)/2(Ř£ 6řþ|"



(b)

CaP-HDz/RNA ".0ńÕ2
siRNA

âĈ! RNAi 5ÌĹ/Þÿ!Úĭ RNA R' 6. (a) ÷ÜíÕõüßòèàöúØ V:
Y¦ V: Y= 3 K; (b) Y= 3 K½Á÷ÜíÕõüßg` (Copyright2014 American Chemical Society)T?ae7ßÄ2(20

×K;fçòǉƩǍŖ Ŗ No.45 (2014 July)ÙÜŖ ³Ŗ ǎŲƀŲŖ ŬŧšůǏ
s_f_fŇ đfçòŇ ×)°;f)ŀǎÕdÙçòjǏŖ 7
tabata.shigekazu.825@m.kyushu-u.ac.jpŨžyſŗ×KìfçòǉƩǍŚÁżŻŴŲĨśżWõŮƐºƔŝŲųţŗĥżŜƏŢŹŞũūŝƆŮŘ
ëſŗ[ħîƆŸſ

s_ftfçòŇżŠŝŷŗôąĆ!×ǎÖǌDNAž)°¡ÃżńŮƐçòżAƏāƇƆŬŲŘ>[ħîšƎſFŭť

st¶_f ǏžƊŹŸ

s_fž×Ņ=fçòżíƏŗ0:i!×ǎÖǌ<ÅĶ_f ǏžƊŹŸŗűƑƆŸŹſ%ťÞŻƐçò'lŸŜƐ#ßþċĕŎžBlž·Ĵ×ÑfâçòżAƏāƇŗ2008vżfƔAŬƆŬŲŘűŬŷŗ

vž4«ż

s

_fđfçòŇž7żØŪƑŗÖSſÕdÙa!×žçòjżŷƩǋƵƞĬžƠƿƜǈǆƺǈ;ÃžŃáŗŠƍƁűžØçòżAƏāƕŸŝƆŮŘ
žƍŞŻĂ½ŸŮžŸŗ§¿ſƩǋƵƞĬžƠƿƜǈƴƗƛǊƥǍżńŮƐĨƔĦƈºŢ^ŝžŸŮŢŗ®ðŸſphoto affinity labelingżƍƏđ1žØºxƔ)dǉƺǈŸĜ£ŬŲĨŗþċ'ƩǋƵƞĬžÄƔ.ŮƐÃżńŮƐĨŗűŬŷ`Í\ƩǋƵƞĬžå

ØĜ°ÃżńŮƐĨ

ƔũÿŬƆŮŘ
A propofol binding site on mammalian GABAA receptors identified by photolabeling
G. M. S. Yip, Z. -W. Chen, C. J. Edge, E. H. Smith, R. Dickinson, E. Hohenester, R. R. Townsend, K. Fuchs,
W. Sieghart, A. S. Evers, N. P. Franks
Nature Chem. Biol. 2013, 9, 715-720.
PropofolǎR 1u ǏſÖSÛŸªƊwťƓƑŷŝƐŕĻ
đž1ŵŸŗűžØºxżŵŝŷſ

ŻŠ£ŻÌŢ^ť¾ŪƑŷŝƆŮŢŗÖ¦ÌŸſŗγ-ƖƿƳļľǎGABAǏžBl
ŸŜƐGABAABlŢªƊĿĘŻ¹â)dŸŜƐŹĈşƎ
ƑŷŝƆŮŘGABAABlſ5ïŒžƣƸǄưƫƭŢ¸řŻ·873 GZXYXQXU4  5 ` a l k \ZSQU]XZXVP\R^U3
OSL_SZSWP odfpu4 53Ÿ5ŁƔŮƐŨŹŸºČŮƐCl–ƪǃƲǈŸŗ
\ Þ U β3 ƣ Ƹ Ǆ ư ƫ ƭ ž Ƴ ƫ ƞ Ɨ ǋ ƾ Ƙ Ʀ Ÿ ſpropofolžŕĻ8±ŢőĐż{ťŻƐŨŹšƎŗØ        ºxžçòſGABAABlžβ3ƣƸǄưƫƭżŉ



 

ŬŷŝƆŮŘŬšŬŗ\ÞƔØŝŲĜ°Ÿſŗ\Þp$żƍƐºČƂžŏžCČŢŵţƆŹŞ
ŨŹżŻƐŲƉŗĐĉƎſphoto affinity labelingŢC
ČŻgČYŹŬŷtrifluoromethyl diazirineYƔp$ŬŲpropofolƖƯǊƟǎR 1D ǏƔEŬŗŨƑŹŀ×
UGABAABlƔŴŷpropofolžăEĺƔĜ°ŬƆŬŲŘ
ƆůŗSf9þċǎ¢ĒþċǏGABAA Blżα1 ƣ973  6GA *MULNTh OGA *4ZPO5jxx
t3

21

×K;fçòǉƩǍŖ Ŗ No.45 (2014 July)ƸǄưƫƭŹβ3ƣƸǄưƫƭƔ}.áÖŪŰŗűž(ŬŲĎÚ)Ɣortho-propofol diazirine(o-PD)ŗŠƍ
ƁĿÂü;ŬŲo-PD(dPD)Ÿ¹ĩŬƆŮŘŨƑƔLC/MSŸĜ°ŮƐŹŗo-PD¹ĩŹdPD¹ĩŸſMSżŠŝŷm/zż1žķŝŢ×ŭƆŮŘƌşżŗĉžƾƦƦƻƞƭǈƔĿŽEƓŰƐŹŗ¹ĩĺƔHƈƷǆƟǁǋƭžƶǍƞſm/zŢ1ųŦůƑƐŨŹżŻƏŗŨžƧǉƔä?żŮƐŨŹŸŗŜƐƤƟƯǈžš
Ǝo-PDżƍƏ¹ĩŪƑŲƷǆƟǁǋƭƔl¤ŗšŵ¼èżFhŮƐŨŹŢŸţƆŮ(R 2)ŘžƍŞŻĜ°ž
ă±ŗo-PDſGABAABlβ3ƣƸǄưƫƭžH267žƇż&¬ăEŬŷŠƏŗŨžHisƔAlażćŬŲ\Þſŀ×UżÀƃŷŗþċŸžƖƫƨƗżŠŝŷ o-PDżnŮƐ÷ŢőĐż{ťŻŴŲŨŹšƎŗ
H267žIQŢpropofolžăEĺŸŜƐŨŹŢ£ƎšŹŻƏƆŬŲŘƼǂǊƥǍǂƬǇǋƟżƍƏ·ùŪƑŲβ3ƣƸǄưƫƭžǂƬǈ·ĴŸſŗFhŪƑŲpropofolžăEĺſ1ŵžβ3ƣƸǄưƫƭžƇšƎ·ŪƑŷŠƏŗ5ŁŹŬŷºČŮƐGABAABlŸſ·ŮƐβ3ƣƸǄưƫƭžżƍŴŷŗBlűžƊžżăEŮƐpropofolžſ\9ŮƐŨŹŢêMŪƑƆŬŲŘ¸řŻƩǋƵƞĬžó·ĴŢĜ£ŪƑŵŵŜƐŹſŝşŗGPCRǎG protein-coupled receptorǏƔſŭƉŹŮƐėOĎīĳƩǋƵƞĬžă©·Ĵ
Ĝ°ſÍŹŬŷPŋŸŜƏŗŨžƍŞŻƩǋƵƞĬżnŬŷphoto affinity labelingſºČĜ°žŲƉž}4ŻÃżŻƏ

ƐŨŹƔŗ®ĨſêŬƆŬŲŘ

Palladium-triggered deprotection chemistry for protein activation in living cells
J. Li, J. Yu, J. Zhao, J. Wang, S. Zheng, S. Lin, L. Chen, M. Yang, S. Jia, X. Zhang, P. R. Chen, Nature
Chem. 2014, 6, 352-361.
Ŗ ƩǋƵƞĬžºČƔ.ŮƐ)d;EÑƋÃſ^ťŃáŪƑŷŝƆŮŢŗűžƄŹƕźſ¹âƩǋƵƞĬžÄ
ƔņkŮƐ¡ÃŸŮŘ¡Ÿŗ¹âƩǋƵƞĬƔÄ;ŮƐrŻŝÃž1ŵżŗchemical rescue strategyŹŝŞ¡ÃŢŜƏƆŮŘŨž¡ÃŸſŗ¹âƩǋƵƞĬžÄĺż\ÞƔp$Ŭŷ¦âżbÄŬŲÓŸáÖŪŰŗġđÆ
5Żźž]ĺ/ÊżƍƏ®¯žÄŢOŮƐŗŹŝŞº·Ÿ¹âƩǋƵƞĬžÄƔ.ŬƆŮŘ®ĨŸſÄžLys¾YƔ¹âżŬŷŠƏŗ ε-NH2 YƔpropargylYŸ:73 + K gvwcnf E^[ o.i{t,id`#+embhgemĪŬŲō`ÍƖƿƳľƔĺÒÞâżp$ŬŗŨž\ÞƔáÖŪŰŲżƵǆƥƘǀ(Pd)ĝ
cƔ5şŷčĪŮƐŨŹŸŗžƩƗƿǋƟŸ®¯žÄƔO
ŪŰƐŗŹŝŞ
ơǋƨƹƭżŻŴ

;73L5~j-`alk M5(df#+)%3

ŷŝƆŮ(R 3)Ř
Ŗ ĐĉƎſƆůŗrhodamine 110žNH2Yżpropargyloxycarbonyl(Proc)YŹallyloxycarbonyl(Alloc)YƔp
$ŬŲǂƬǈ;EÑ(R 4a)ƔØŝŷĸ*ŻĪYŹčĪġđ(Pdĝc)žµĞƔēŝ(R 4b)ŗProcYŹ

22

×K;fçòǉƩǍŖ Ŗ No.45 (2014 July)PdĝcC5žāƇEƓŰŸƊŴŹƊ8ÔƍťčĪŸţŲŨŹšƎŗ»żŨžāƇEƓŰƔǂƬǈƩǋƵƞ
ĬŸµğŬƆŬŲŘŨŨŸŗĐĉƎſþċ'žƩǋƵƞĬż®ûƔØŮƐż~ŲƏŗǂƬǈûŹŬŷĭà
ďŢŵphosphothreonine lyasež1ŵŗOspFƔĹƁƆŬŲŘOspFſĭàďŢ¬ŮƐlyase(ĿăEž

@ƔĝcŮƐĽü)žïŸŗűžÄŸſLys134ŢĿĘŻ3ƔŴŷŝƆŮ(R 5a)ŘĐĉƎ
ſOspFžLys134Ɣŗ ε-NH2YƔProcŸĪŬŲLysĤp(Proc-Lys)żơƮǋ|żƍƏĺÒÞâżć Ŭ ŗ b Ä Ŭ Ų Ó  (OspF-K134-Proc-Lys) Ÿ HeLa þ ċ ż } . á Ö Ū Ű Ɔ Ŭ Ų Ř Pd ĝ c Ż Ŭ Ÿ ſ ŗ
OspF-K134-Proc-LysƔ}.áÖŪŰŷƊǇǋľ;Erk(p-Erk)ſčǇǋľ;ŪƑů(R 5b ǉ Ǎ ǋ 4)ŗPdĝc
Ɣ5şƐŨŹŸ+Ɖŷp-ErkŢčǇǋľ;ŪƑƆŬŲ(R 5b ǉ Ǎ ǋ 1,2)ŘƆŲŗXTżProc-LysƔ5şŻŦƑƀŗOspF-K134-Proc-LysƔáÖŸţŻŝŨŹšƎ(R 5b ǉ Ǎ ǋ 3,6,7)ŗOspF-K134-Proc-Lysſèšż
Proc-LysƔAƏİƕŸŠƏŗűžĝcÄſPdĝcƔ5şƐŨŹŸ+ƉŷOŮƐŨŹŢèģŸţƆŬŲŘ
ý]"ÎoŸčƠǍƥƮ;ŮƐÃƊŜƏƆŮŢŗý]"űžƊžż÷Ŭŷþċ'žǇǋľ;ƤƟƯǈ
ƜƦƠǍƮŢ\;ŮƐŨŹŢŜƏŗ®Ãſűž¸Ż]ĺ/Êž2ØŢŻŝ<73L5F[YC j/ƑŲÃŹŝşƆŮŘ

sy`alk M5!"gj0 BZT j#0p}zq3

The hepatitis B virus preS1 domain hijacks host trafficking proteins by motif mimicry
M. C. Jürgens, J. Vörös, G. J. P. Rautureau, D. A. Shepherd, V. E. Pye, J. Muldoon, C. M. Johnson, A. E.
Ashcroft, S. M. V. Freund, N. Ferguson
Nature Chem. Biol. 2013, 9, 540-547.
²žBUĊËƘƗǈƦǎHBVǏžƘƗǈƦúdſŗƱƞ
ǉƛƜƹƤƮǎơƖúdǏŢ3ïŒžƘƗǈƦĕŎƩǋƵƞĬŸ
ęƓƑŲ·żŻŴŷŝƆŮŘĕŎƩǋƵƞĬž1ŵŸŜƐL
proteinſmþċ'ŸáÖŮƐŹŗqċĎżėOĎīĳžÓŸƷƚǍǈƮŬƆŮŢŗ2ĳƏžƷƚǍǈƮ¸zŸeSŮƐŹĈşƎƑŷŝƆŮŘ1ŵſPreSƮǁƗǋǎR 6ažpreS1+ preS2ǏŢcytosolǎqċž]ǏżŌ(ŬŲi-preS LŹJƀƑƐÓŸŗƊŞŵſPreSƮǁƗǋŢlumenǎqċ'ĺǏƔGŝŲe-preS LŸŮǎR 6bǏŘŨƑƆŸżŗi-preS LŢ
γ2-adaptin Ź J ƀ Ƒ Ɛ Ʃ ǋ Ƶ ƞ Ĭ ž EAR Ʈ ǁ Ɨ ǋ ǎ   ŗ
γ2-EARǏŹå

ØŮƐŨŹŢ£ƎšŹŻŴŷŝƆŮǎR 6cǏŘ

23



3
=73L5D@J &2{t,jq-`M5
"$gj r`alk
N5γ96LOLY\SW jq-3 3

×K;fçòǉƩǍŖ Ŗ No.45 (2014 July)
γ2-adaptinſŗƩǋƵƞĬžþċ'įĲżńƓƐƩǋƵƞĬŸŗi-preS LżƍƏƢǈƥżįĲŪƑƐŨŹŢèģŪƑŷŝƆŮŢŗűžĢþŻåØ¸zżŵŝŷſƍťƓšŴŷŝƆŰƕŘűŨŸ®ĨŸſŗ´éÁ&ŔÃǎNMRǏŹöÇÉhUÏŁÈhǎITCǏŻźžÃƔœŬŷi-preS LŹ
γ2-EARžå

ØƔĢþżĜ°Ŭŗi-preS LžåØĺžFhƔ

ġƇƆŬŲŘŖ ĐĉƎſŗPreSƮǁƗǋžŸƊ²żĿĘŻ3Ɣ±ŲŮŨŹŢæƎƑ

>73 GZPI8 qjjδ3ŷŝƐPreS1ƮǁƗǋżĄƏŗĜ°ƔēŝƆŬŲŘƆůŗγ2-EARżPreS1ƮǁƗǋƔÉŬŲňžHSQCǎheteronuclear single quantum coherenceǏƦƻƞƭ

p0& 873GZPI8 |hγ96B?H j'13

ǈž\;šƎƖƿƳľũŹżchemical shift perturbationǎCSPǏǎŗδǏƔø(ŬŲŹŨƒŗPreS1ƮǁƗǋŸſ29-41Ýäž¾Yżŷ_ţŻδƔêŬƆŬŲ
ǎR 7ǏŘå
žåØżńƓƐŐVſ_ţŻδƔêŮŲƉŗŨžŐVŢγ2-EARŹØĺŸŜƐŹÈŪƑƆŬŲŘ»żŗ29-41Ýä]žŐVƊHƉ

ŷpreS1ƻƹƪƮÐžγ2-EARżnŮƐěLƔITCŸĠŬŲŹŨƒŗPreS1

ƮǁƗǋżſγ2-EAR ŹåØŮƐŐVŹŬŷŗ9-16Ýäŗ29-36ÝäŗűŬŷ



59-68Ýäž3ŵŢeSŮƐŨŹƔĚŝųŬƆŬŲǎĕ 1ǏŘªżŗPreS1ƮǁƗǋŹγ2-EARžėEżŵŝŷŗ 15N-1H heteronuclear NOEŹion mobility spectrometry-mass spectrometry
ǎIMS-MSǏżƍƏĢþżĜ°ŬŷŝƆŮŘIMS-MSÃŸſŗƗƛǋž_ţŪǎñǏŸ)ŊŮƐIMSĺŹĬŁ
)°ĺƔĵăŬŲĖćƔØŝƐŨŹŸŗm/zǎ)dŁǏŢFŭƩǋƵƞĬŸƊŗơǋƵƞƭżƷƚǍǈƮŬŷ
ŝƐƩǋƵƞĬŹŗƷƚǍǈƮŰůżƻƹƪƮłŢƁŲÓžƩǋƵƞĬŸſ,žƤƟƯǈŹŬŷµ(ŪƑƆŮŘƆůPreS1ƮǁƗǋſ`Í\ƩǋƵƞĬǎintrinsically disordered protein; IDPǏŸŜƏŗƄƅ
extended formƔAƐŨŹŢNMRżƍƏèģŪƑŷŝƆŮŘŬšŬŗγ2-EARŹăEŮƐŨŹŸĺž·ĴžƎŤŢqŪťŻƐŗŵƆƏhž·ĴƔAƐŨŹŢŗ15N-1H heteronuclear NOEšƎ£ƎšŹŻƏƆŬŲŘŪƎżIMS-MSžă±šƎŗγ2-EAR-preS1ėEſ2ïŒžơǋƼǁǍƤǅǋŸeSŮƐŨŹŢèģŪƑŗŨƑſ
preS1ŢơǋƵƞƭƏŲŲƆƑŲŗƊŬťſƽǇƻƹƪƮłŢƁŲơǋƼǁǍƤǅǋŸγ2-EARżnŬŷăE
ŬŲÓƔ@¥ŬŲƊžŸŜƐŹŗĐĉƎſăĨŶŦŷŝƆŮŘªĀâżſŗ

ƎƑŲæĚƔĮƆşŷmþċ'ŸžHBVƘƗǈƦúdžǁƜưƧǀƔNŬŷŝƆŮŘ®ĨŸſŗNMRŗITCŗIMS-MSŹ¸řŻ)°ÃƔœŬŗIDPžå

ØǁƜưƧǀƔĢþżĜ£ŬŷŝƆŮŘIDPžƍŞżhƆŴŲ·ĴƔAƎŻŝƩǋƵƞĬžă©·ĴĜ°ſŋŬťŗ®ĨſŨžƍŞŻƷǉƝƤƸǈŻƩǋƵƞĬžå

ØǁƜưƧǀžĜ£żŠŦƐŗƍŝǂƬǈƠǍƦżŻƐšƊŬƑƆŰƕŘŖ ŗƩǋƵƞĬžƠƿƜǈƴƗƛǊƥǍçòžĨƔǐZÿŬƆŬŲŢŗÒżſŭƉž2Zſ-ØŬŷŝƐ;f@űžƊžſƤǋƹǈŸŗŨƑƔƩǋƵƞĬ;fŗþċ×ÑfžĔŗæĩŹāƇEƓŰƐŨŹŸü¨ƎŬŝżŢŴŷŝƆŮŘªžĨŸſŗă©·ĴĜ°żƍƐåØº·žĢþŻĜ

£ŢŋŬŝIDPżŵŝŷŗ¸řŻ)°ÃƔœŮƐŨŹŸŗă©·ĴĜ°żƊ6ƎŻŝĢþŻƬǍƩƔ
ƎƑƐŨŹƔiğŬŷŠƏŗ

žIDPçòžŵžǂƬǈŹŻƏ

ƐĨŸŮŘıvŗ¸řŻ;f@ŗ)°ÃŢƩǋƵƞĬżƊĸØCČżŻƏŗŨƑƎƔœŬŲ¸řŻƩǋƵƞĬžºČĜ°ŗűŬŷƙǋƥ
ưƖǇǋƟŢƆŮƆŮãƕżŻŴŷŝťƊžŹ­ŪƑƆŮŘ

24ŝlSŶƅˆʤˌɂ ɂ No.45 (2014 July)(+*',)&$!  !" %      !""#"  % 
tamura@caltech.edužɰ2013µ3đɭȐľyĠùêɯɽɪɩʇ^ÅÄɆeµ5đɐʁĄĖǂèƱŖDŶƅnˎw=èˏɯŀŇƳF¹ʇEşɜɨʑ˄ʴʏ˅ʭʉ®ſˎCaltechˏLinda Hsieh-WilsonŶƅ
ɭŤɜɨɌɹɞɇɘɯ¹Ɇ5ĞɭɽŤ!ȿʇ}iɞʃĪʇȵɒɹɜɣɯɩɆŤɭƯʃƙƞɾCaltechɩɯŶƅŝļƉɭɧɌɨƘɚɠɨȵɒɹɞɇ{ƈŚxɩɥɿɍɫːµɯŵɌŤƙȿɩɰɋʂɹ
ɞɑɆĖƄɑÄŀɩɯŶƅʇǎŢɜɨɌʃŝɚʈɾʻʟʫʕɯŬɚʈɯɏÁɭ¨ɜɩɽƇɨʄɱ¶ɌɩɞɇɬɏɆŝlSŶƅˆʤˌNo.18ɭɰɆġȓǷ4ŝɑʀʂDeepɬCaltechŤ!ȿǏʇ{ƈɚʄɨɌɹɞɯɩɆCaltechɵɯŤʇɏƤɎɯĀɰɢɥʁɽdʆɠɨəǋȵɔɪɜɌɐɪÌɌɹɞɇːɆŇ Ƒ ɹɩ ɯ ƙ ƞɂ žɰtɯŤHɭɆXǝƂ1µɯ1đɐʁ4đɭɐɖɨʋʔ˄ʟɆʐʦʕʟʴʏˌʫˎBenjamin G.
DavisŶƅˏɭŌxɜɣɘɪɑɋʂɹɜɣɇCɼɨɯŀŝļɰƹLɯȃƜɩɜɣɑɆÜɬƺǛʇȾ$ɜɬɑʁwƐɬʿˉʰˌɪǤǠɞʃɯɰGŎūɩĥɜɌƙȿɩɜɣɇĀɆŶƅȳɭɏɌɨɰɋɹʂØĜʇɋɗʃɘɪɑɩɒɬɌɹɹɆɋɦɪɌɍȞɭ²wɯĄʇǼɎɨɜɹɌɹɜɣɇɘɯɪɒĄĖɭgɐɍȻǁĪɯɩɆɉ3ˊđɩɰŕǱʂɬɌˍɊɪɌɍĳåɥɑƷŝɎɆɘʄɑtɯŤɯɒɬɒɦɐɖɭɬɦɣ

ʀɍɭÌɌɹɞɇɢɯÄɆD2ɯ3đȶɭƕ#ĎáʇƙɨʉʑʩʽʦʕɯȊɭȄɻǊÑʇĶɼɆʻʟʫʕĔȞɰöɼɨŀɩÿɜɌɭçÚɜʀɍɪĶÔɜɹɜɣɇɢɘɐʁÍɓɩĄĖǂèƱɯŀŖDŶƅnˎŀèˏɯšǟŋ-ʇɼɣɯɩɞɑɆįËɬɑʁƚĜɰëşɩɜɣɇĀ¶ȈɭɽɆeĊĔɭšǟɜɨɌɣw=èɭëşɚʄɆ^ÅÄɰęĻĖĿ´4ŝɯŶƅɭÛ¬ɚɠɨȵɔɘɪɭɬʂɹɜɣɇəŴɯĀɽɌɪÌɌɹɞɑɆw=èɰĔ3µɯɍɥ1µUɯŀŇƳɑǚɼʁʄɨɌɹɞɇɢɘɩŀŤʇ½ɔægɜɨɌɣžɰɆĻĖ4ŝɐʁɏǒɜʇȵɌɨɆĔɯHUʇŤɭ3ɨʃɘɪɭɜɹɜɣɇ
ɂ XǝƂɭɏɌɨɆžɰʤˉʱʕǭɯȍâūS(ȽÜĹɯȜũɭôʆɦɨɌɣɯɩɞɑɆBen DavisŶɵɯŵĔŤʇĪɭGlycobiologyɭɽƱkʇåɥɼɨɌɹɜɣɇɢɘɩw=è=ůÄɐʁɆ¾ǗAȓɯɌɔɧɐɯ˃ʺɭʻʟʫʕɪɜɨ_ɖ7ʄɨɽʁɍʀɍɏȺɌɞʃʿˌ˅ʇȀʂɹɜɣɇɜɐɜɬɐɬɐ
ƵɌǾɑɽʁɎɟ(ɪɌɍɐǾɞʁɽʁɎɟ)őʂɰɝɼɣD3ɯ12đȶɆɢʄʇǇ<ɮɣľy4ŝɑɆžɯʇŚxɯʺʟɩɋʃLindaɭƘɜɨɚɌɹɜɣɇLindaɰŻƙȋɾŦŧɭɏɖʃƒșɯĪƫɭ

25ŝlSŶƅˆʤˌɂ ɂ No.45 (2014 July)ȟɜɨŶƅɜɨɌʃÿȄĳȗɯÎŶƅƥɩɆǽɈŝɑ"ɐVģɞʃɯɩžʇʻʟʫʕɪɜɨ_ɖ7
ʄʃ#yɑɋʃɪɯɘɪɩɜɣɇÂɯɭƱkɯɋɦɣžɰɞɕɭCVˎƺü­ĮďˏʇȀʂɆľy
4ŝɆƍyŲ

4ŝɆń

ƻĩ4ŝɭďɌɨȵɌɣîƽŗɯÄãɜɽɋɦɨŐëşɭƯʂɹɜɣɇžɯ~dʴʍˇˌʝʦʶʇåɦɨɏʂɆɹɣĄĖɭɌʃɘɪɽɋɦɨȳíƉɰɋʂɹɠʈɩɜɣɇVģHɯÉɜɌĊĔɭȳíʇ6ȤɜɨȵɌɣɘɪɰ¶ȈɩɜɣɑɆÌɍɪŐśɜɨɩɽǐpɜɨɏɌɣɷɍɑ˃ʺɯȮvĳɾLindaɯĝɬɫɑHɭAɐɦɨŇƑHɯɰmʁɌɤɐɪÌɌɹɞˎP. G. Schultz Ŷ@ǳ
ɯLindaɰSlave driverɐɽɃɪɌɍqɑɋʂʲʕʲʕɜɨɌɣɽɯɯɆȩɰɢʈɬɘɪɋʂɹɠʈɩɜɣˏɇˑɆʱ ʛ ʩ ʬ
ɂ Caltechɰˇʛˉʢ˅ʟTęɭƠɞʃʱʛʩʬ°ɯǃɭɋʂɹɞɇʱʛʩʬɰȝȱɬɁƖɜɨŴʁʄɆaɌˆˉʒȂʂɯ»ŕʇEşɜɣʝ˂ʦʳˉʖˀˌ˅ɰ

ǃɪɔɯɩĉǫʆɦɨɌɹɞɇɹɣɆ

İµ1đ1ĄɭǁʆʄʃɉˇˌʠʱˆˌʫɊɪɆʑˆʦʞʴʦʪʺˌ˅ɯɉˇˌʠʺʌ˅ɊɯȜ.yɪɜɨ8ƑūɭĒfɩɆ2ąɭɰ100ʇǰɎʃɈɑʱʛʩʬɭãɜ¡ɠɹɞɇǃɰ8!ūɭķɑƵɔɆȆɔ
ɭ@ĭɌɨɽYȦʇÖɝʃɘɪɰɋʂɹɠʈɇɽɥʅʈ~ÛɭʀɦɨɰɾɾȮvĳɯÒɌ~ÛɽɋʂɹɞɑɆ
|ĖūɭɰĄĖɪɚɷɫʆʁɬɌÖǊɩɻɘɪɑɩɒɹɞɇ*ɰµʇȁɜɨȭɑɷɪʈɫȡʁɟɆŔɾɐɬȰƆɯĄɑƜɒɹɞɇˇʟʀʂɾɾ=ȥɭƠɞʃʱʛʩʬɰɆɰĄ¯ɜɑɒɧɔɆĄɰȃ

Ą100 °FˎƔ37.7 ɄˏʇǰɎʃČɚɭɬʂɹɞɑɆɰĳɭĳňɑɑʃɯɩĄĖɯʀɍɬœ±ɰɋʂɹɠʈɇ>ɰĄĖɪıɶʃɪňčɩɞɑɆUǄɩ3AɪɌɍɕʁɌČɔɬʃĄɽɋʄɱɆ?Ɏʃɷɫ¢ɔɬʃɪɒɽɋʂɹɞˎʑ˄ʴʏ˅ʭʉɤɜɃɪɆɣɐʇɔɔɦɨZÜɯȠ¢;ʇåɦɨĘɨɌɬɐɦɣžɰµĕɭȒƎɬʋˉʴ˅ʎˉʜɭơʂɹɜɣˏɇǃɯȮvĳɑƵɔɆˇʟɐʁɽǴɩ2030AƂɪǽɌɯɩɆĄĖɽɔʈɩɏʂɆĄĖȼˆʟʪ˃ˉɾĄĖɯȼėɑÜɭ7ʃʟˌʱˌɽ3ɜɨɌɹɞɇɹɣ°Ĳʛˌʲʟ

ɪɜɨɆʱʛʩʬʝʨʊʑˆʦʞɩɰǜɩɽ\KɩɒʃŐýɯESLˎEnglish as a Second Languageˏʕ˃ʟʇ
ȜǡɜɨɌɹɞɇžɽɽ_ǡɜɨɏʂɆħɈɬwɐʁɯƁĲɣɥɪƝɭťüSĽɜɬɑʁƺǛɾʉʿ˄ʑɯüSʇN½ɜɨɌɹɞɇ

ɂɂˇˌʠʱˆˌʫɯħɇ

ɭɰ~Û^ʂɯɣɼɭċĄɯʇǲɩ BBQ ɜɬɑʁȉəɞɽɌʃɇ

26

ŝlSŶƅˆʤˌɂ ɂ No.45 (2014 July)˒Ɇÿ ŝ ļ ɯ Ƈ ɥ  ɗɂ žɯ~dɆŇƑÄ3ĄɩʉʱˌʪƔɪȖǁ`ºɯȜǑɆ7ĄɩǴɯǮ7ʇŅɹɠɆɋɪɰ¨ɜɟɧ;ˋɂȯʇðɎɨɌɒɹɜɣɇ
ɔɯŤŝeħɆìɜɑĐɯȬȟɩɜɣɇʱʛʩʬɯ

ǪɰęȐÇɭɁɔɆCaltechjǺɪɬ

ʃɪStudioˎˈˉ˅ˌʾʤʋʶɯȏ«ˏɩđ$900Ɇ1bed roomˎ1LDKˏɩ$1200ɔʁɌɑŰ~ɭɬʂɹɞɇ
ɷɪʈɫɯŝɰ£ɭ7ʃɐ˅ˌʾʝʍʉɜɨ$600ɔʁɌɭàɎɨɌɹɞɇˇʟǽȎɭɰʉʱˌʪʇþĂɜɨɔʄʃOŞ«ɑɋɹʂɬɌɯɩɆŇƑůÄɐʁʹʨ˅

ɹɌʇɜɬɑʁƮAɩĭɒtɦɨFor rentɯűĚ ɯ ɋ ʃ ʉ ʱ ˌ ʪ ʇ ì ɞ ɯ ɑ  ƴ ū ɐ ɪ Ì Ɍ ɹ ɞ ɇ ž ɯ ~ d ɰ Ǫ Ǩ Ó } ʛ ʋ ʪ ˎ Craigslist, Zillow,
PadmapperɬɫˏɩƆɒȏ«ɯŮĈʇɖɆɢɯjǺʇĭɌɨķɾŝļɯE&ÎɬɫʇŷǚɜɨɐʁɆ
ʉʱˌʪɯ

ɚʈɾƊśźʇǐpɞʃɪɌɍÜĹʇɪʂɹɜɣɇŒʂɧɖʃȧɯɨìɜɹʆʃɯɰɩɜɣɑɆǃɯÇɪɯɫɥʁɭɽǽɔ

Ɇ·Ɍǃ

ʇĭɌ

ǪɽŰ~ɐʁɞʃɪɼɯ$1065ɯ

1bed roomˎȯĳɆĴȊɆʒʟǻɺˏʇǇɧɖɹɜɣɇɘʄ¶ɌɪÜɬƺǛʇȾ$ɜɬɑʁƔɜɣɽɯɯɆɌɛʈɩɺʃɪ'ɝʁʄɬɌúɯʚɅʵ˄ɑŝÏɜɨɏʂɆŇƑĆɈƛēɜɣɯʇǊɎɨɌɹɞɇoɯøɌɰɘɥʁɯɽɯɰıǵū§ɚɔɆOɒɽȆɌɯɩƏWɭǿķɩɒɣɘɪɩɞɑɆɭɽʕˀɾʙʐ
ˇʔɆʘʞʘʞɬɫɽĊáʱʛʩʬɩÙɑɂɭȇɳɭɾɦɨɔʃɯɩĄɈƿȋɪɯÚɌɩɞɇˎĺ˖žɯŴʃȢʂɘʈɬɰɤɖɩɞɯɩɋɜɐʁɟˏɇ

ɑĶɹɦɣʁɞɕɭŚyɯȖǁɩ`ºʇȜǑɜɆǴʇǮ7ɜɹɜɣɇʱʛʩʬɾˇʟ

Çȏɰʰʟɾʿ

ʪˇɑɋʂɆǴɑŐɔɨɽ"ɪɐŝļɩɒɹɞɑɆɾɰʂǴɑɋɦɣɷɍɑǧɌŕɬɫɭ&EɩɞɜǁOƌvɑ·ɑʂɹɞɇʉʿ˄ʑɰŕʇɭɞʃwɬɯɩɆĄĖɩɰɋʂÅɬɌɔʁɌaɌǴɩɽŚÁɩǯɦɨɌɹɞɇĄĖǴɰ÷Ȫɑ¨ɬɌɣɼŖɭĳɑɋʂɆžɰʩʊˌ˃ˌɐʁ

aɯ98µ¼TOYOTA CAMRYʇǮ7ɜɹɜɣɇɚɞɑɭzɑaɌɯɩCɼɰɩɜɣɑɆɪɨɽʀɔǯʂɆƚ©ɘɯǴɩʛˉʴ˃ˉʝʟ
ʙɆʬʱʰˆˌɆ˃ʟʷʒʟɆʩʟʰˆˌɬɫƶʈɬÛɭʫ˃ʋʵāǁɜɹɜɣɇŚyɩɯ6ǒǔɆSocial
security numberɯ^ÅƉɰɏɏʀɢʉʿ˄ʑŤʛʋʪɭïǶɚʄɨɌʃÓ}ɯȁʂɩɆɯŤŝgɖʐ˄ʎˉʨˌʝ˂ˉɩɽǘɜɌÓ}ʇùɎɨɔʄɹɜɣɇɂ ÿŝļɭÈǆɬ;Ɇȯɰ°=ɯȔǦ¸ɩɽÜɭ7ʂɹɞɑɆCraigslistɾɉɳɳɬɳɊɪɌɍĄĖʙʽˁʭʨʊˌʛʋʪɯ)ǧşïŸĚɩǇɧɖɣɷɍɑɑʂɩɞɇɹɣɆCaltechɯʻʟʫʕȞɩɰÓ}:Ēşɯʿˌ˄ˉʖ˄ʟʪɑɋɦɨɆmoving saleƉɯÓ}ɑȷƟɭªɔɯɩ"ɐīɜɌɽɯɑɋʃĊɭɰɪ
ɨɽ&EɩɞɇÿŝļɯƇɥɗɰȲ³ɭLJʇǆɜɹɞɑɆƺǛɩņɜɣʂɆuȬʇʂǰɎɨɌɔ

ȉƂɰɌɹèʂǾʃɪƵɌÌɌ@ɩɞɇ˓ɆCaltechɂ ʑ˄ʴʏ˅ʭʉ®ſˎCalifornia Institute of TechnologyˏɰɆCaltechɯÕƀɩǌɜɹʄʃſɪ®Ŷƅɯ¥țɩɞɇȏŝƔ900ɆȣŝƔ1,300ɆʻʟʫʕƔ600ɆùnƔ300ɯɆ§ǈĨɬɩɞɑɆɘʄɹɩɭ31ɯʯˌʷ˅Ǭ_ǬƥʇǸ@ɜɨɏʂɆɢɯɍɥ5ɰɽŚÁɯùêɪɜɨŶƅʇƜɖɨɌɹɞˎžɯŶƅɯɯȨɭɰRobert GrubbsɑɌɹɞˏɇeɝ®ſɩɋʃMITɪıǵɞʃɪCaltechɯŴf¹ɰĄĖɩɰɋɹʂɁɔɬɌʀɍɭÖɝɹɞɑɆƺɁƉùƩ¥țǙɉTimes Higher
EducationɊɭʀʃţ˃ˉʓˉʖɩɰ3µȃƜːɭɬʃɬɫɆfțɪɜɨŴʁʄɨɌɹɞɇ

27

ŝlSŶƅˆʤˌɂ ɂ No.45 (2014 July)ɂ CaltechɭĘɨɹɟɀɐɚʄɣɯɰɆſɑ.ɞʃäÃǡōɯúɪǭɯɁɚɩɞɇţʪʦʶˆʷ˅ɯŶƅƥɭʀʃäÃǡōɑüȁʂİĄɯʀɍɭ.ɚ
ʄʃɣɼɆ³ɭɢɯAȓɭɏɖʃĐÿɯŶƅOgʇŴʃɘɪɑɩɒɹɞɇɜɐɽĊɭFaculty*ǅˎ˗ˏɪÌʆʄʃƸɔɨ1ŽɬʻʟʫʕɯäÃǡōɽɋʂɆʉʿ˄
ʑɯƸÜŶƅƥɯɁɌJʇƨɩÖɝʃɘɪɑɩɒɹ
ɜɣɇɹɣɆ=ɯȣŝˋʻʟʫʕɭʀʃʡʽʬˌ
ɽŭʈɩɆˎʳʜɪʙˌ˃ɑŐýɩèʃƲʆʄʃɘɪɽ
ɋɦɨˏƧǀɽɔɆŝɐʁɰŴǣʇɫʈɫʈh]ɜɨƮAɯǉȓʇ·ɗʀɍɪɌɍ½ɌÇɑǇɨ^ʄɹɞɇʗʽʑ˅ʰʋʐˇʞˌAȓɯŶƅĢɇɐɧɨɰ
ɋɯ Linus Pauling ɽɘɘɩŶƅɜɨɌɣɇɂ ŶƅŜɰȲ³ɭÐɹʄɨɏʂɆNMRɾǭȔAěƉɯzŉĪrɰ:ȁĪrɪɜɨ-ɚʄɆ¥țɯÞɚʈɑ³ɭʿˉʨʬˉʟɜɨɔʄʃɯɩÊȌɭ$şɩɒɹɞɇɹɣȲ³ɭ&EɤɪÖÇɜɣɯɰɆSſɯŶƅȞɩʮʦʪˈˌʕ:ĒɚʄɨɌʃǕƾƊśʩˌʤʷˌʟɩɞɇɘɯʩˌʤʷˌʟɭŪȘɚʄɨɌʃǕƾɰɆɣɪɎɯ˃ʺɑÛĒɞʃɽɯɩɋɦɨɽƮŠɭ$ɍɘɪɑɩɒɹɞɇŖɭɆɴɪÌɌɧɌɨǕɜɣɌdØʇɞʃĊɾɆɍɦɐʂǕƾʇBʁɜɨɜɹɦɣĊɬɫɆĊȞɯƋƔɭɬʂɹɜɣɇʻʟʫʕɾ
ŝɭ¤ɞʃżEZŝɽ3ɜɨɌɨɆĖĠūɬʞʾɑɌµǩˎžɑĘɣ¾CɰŐýɩɜɣɑĐǽʻʟʫʕɐʁµ$200ɯǩʇ^ʃʀɍɭɬʂɹɜɣɃˏɩ$ɎʃɷɐɆ!đɭ¹Ɇʲˌ˅ɪȼɑŐýɩñ%ɚʄʃSocial PartyɑȜɐʄɹɞɇɹɣɆɑ
ʂɆ.ɞʃȑ,ƥˋăgɖɯʋʷˉʪɾʕ˃ʵļOƉɽɋăȃʄɯʻʟʫʕɾŝɩɽÇɜɨŶƅɭÝɥǻɼʃʀɍɬŜɑûɎʁʄɨɌɹɞɇ

˔ɆLindaŶ ƅ  ɩ ɯ ŝ ļɂ žɯÛ¬ɞʃLinda Hsieh-WilsonŶɩɰŚxɆ (1) GlycosaminoglycanɆ(2) O-GlcNAcSʤˉʱʕǭɆ(3)Fucose-α(1-2)-galactoseɯ3ɧʇŶƅ¤ǥɪɜɆŘƮɭȜũɜɣAʧˌ˅ʇȾ$ɜɨŻƙƓɾƭŨ¿ØɭɏɖʃƒșɯÁIɭɧɌɨŶƅɜɨɌɹɞɇ˃ʺɰPI(Principal Investigator)ɯLindaɆXǝƂŝ7Ɇʻʟʫʕ3ɩĦØɚʄɨɏʂɆĒĪSɆAŝŕɆŻƙŝŕʇʰʦʕʖ˃ʌˉʫɭåɧʿˉʰˌɑȫɹɦɨɌɹɞɇRPĊȞɰŖɭĶɹɦɨɌɹɠʈɑɆɷɪʈɫɯʿˉʰˌɰ´Ą910ĊɭĘɨ18Ċȶɭɰ²ʂɹɞɇLindaɑĵɼʃɯɰȚĊȞL0ɩɰɬɔɆɋɔɹɩɽƚĜɬɯɩɆŬȿɯʸˌʟɭdʆɠɨMřūɭʇɞʃʀɍÇɑɖɨɌʃʀɍɩɞɇžɰ!İĄ9ĊȶŪğɜɆ20-21Ċɭ²ɜɨɌɹ
ɞɇƆɌɣĊȞɭɰbŊɯŝɯʥˌʾɭłɝɦɨʣʴʪʺˌ˅ʇɜɣʂɆɘɥʁɩŴʂdɦɣĄĖɯĀɣɥɪʨʭʟʇɜɣʂɜɨ˄ʴˆʦʝˁɜɨɌɹɞɇɂ ˃ʺʿˉʰˌɰ|ĖūɭŘƇɜɣʨˌʼʇɲɪɧɐˑɧåɦɨɏʂɆŶƅɯȄɼĀɰcƮɭɮʁʄɨ
ɌɹɞɇŝɯŶƅȅǁƫJɰĤɼɨɁɔɆƮūɭɢɯʨˌʼɭɏɖʃǝȸʇǇɧɖjvɯɣɥɪ

ʙ˃ʺˆˌʪɜɬɑʁŶƅʇɫʈɫʈHɭȄɼɨɌɒɹɞɇɏʀɢđɭ1¹LindaɪʼˉʧˌʼˉɩȳǞɞʃ
MicromeetingɑɋʂɆɢɘɩŶƅɯȄéɪÄɯĀȕʇǤǠɜɹɞɇɹɣcƮUµɭː¹ɯIdɩɆʿˉʰˌ8nɯHɩŶƅØĜʇʶˆʢˉɞʃĪɑɋʂɆɾɰʂʳʜʇȼɶɬɑʁļũɬǤǠɑǁʆʄɹɞɇ
Lindaɰ

ÉʇĤɼɨɌɨɘʄʁɯʽˌʨʊˉʖɩÂɪɍɘɪɰɷɸɋʂɹɠʈɑɆcƮɯŶƅŗĸ28

ŝlSŶƅˆʤˌɂ ɂ No.45 (2014 July)ʇʀɔßòɜɆūŷɬSuggestionɩʿˉʰˌʇæ¦ɜɨɌɹɞɇɂ žɯŶƅɯʿʋˉʨˌʼɰɏɏɹɐɭɌɍɪɉʒˉƗƪ/Ĭ³ƗƪɭɏɖʃO-GlcNAcylationɯıǵȔǍěɊɩɆƣǓÄ(ȽɯƃɩɋʃO-GlcNAcSɑʒˉƗƪɯÎǭɾǢɭɫɍɌɦɣÀȴʇɎɨɌʃ
ɯɐʇǍćɞʃɪɌɍɽɯɩɞɇŇƑůÄɭLindaɐʁʨˌʼʤʋʪ˅ɑñŸɚʄɆɋɪɰ˃ʺʿˉʰˌɪǤǠɜɨɌɔɩȿʩʜʋˉʇƤɎɨɌɒɹɜɣɇɾɰʂƺǛɩɯǤǠɰŰ¾ƹLɜɨɌɹɞɑɆ˃ʺɯ

ȞɰŬžɯŐƼƹƼɬƺǛɭɽɬȹɧɠɟœÇɭƦʇ/ɖɨɔʄɹɞɇĒĪdØɾƗƪȿƉɆŝĊɪȿʟʤʋ˅ɑɨɌɣɯɩɞʈɬʂɪŶƅʇʟʤˌʪɩɒɹɜɣɑɆĐǽɰʰʋʐˇʞˌɯŴǣɑÈǆɭɬʃ~ȳɑ

ɔN½ɯİĄɩɞɇɋʃƂ¹ʶˇʞʍʕʪɑƇɥɑɦɣɪɘʅɩɆɌɔɧɐɯ

ģɪ:eŶƅɞʃɘɪɭɬʂɆŚxɰ4ĀɯŶƅnɪʿˌ˅ɩɯɾʂ^ʂɾɆɌɧɹɩɣɦɨɽ×ʄɬɌȯǖǤɭsƹ9ƹɜɬɑʁɽĥɜɔŶƅʇȄɼɨɌɹɞɇ˕ɆĐ Ä ɭɂ ÿɜɌAȓɭçÚɜɣɘɯµȞɰɆĥɜɌɘɪɽɣɔɚʈɋʂɹɜɣɑɆÌɌȁʂɭɬʁɬɌɘɪɾƹɜɌɘɪɰɢʄɭɋʂɹɜɣɇɜɐɜɢɍɜɣƹȬʇʂǰɎɨɌɔȉƂɩɆɌɹɹɩɭɰŐɐɦɣǉŏɾŕɯƤɎĀʇǳɭɧɖʃɘɪɑɩɒɆ¨ɜɰŶƅƥɪɜɨØȚɩɒɣɯɩɰɬɌɐɪÌɌɹɞɇɹɣɆcwɐʁħɬėɑȫɹʃʉʿ˄ʑɩʻʟʫʕɪɜɨȉəɠɣɘɪɰɆƬ¿ØɯŏɩɽɆţɯŶƅƥɯ

QɾJʇƮAɯųɩůɭǇʃɪɌɍŏɩɽžɭɪɦɨɣɌɵʈĒÔƢɬɽɯɩɜɣɇŤɭɰɒɬʎ
ʮ˅ʔˌɑÈǆɩɞɜɆ˄ʟʕɽ¨ɬɐʁɟɋʂɹɞɑɆŀɭǁɐɬɖʄɱÅʁʄɬɌƙȿɑɣɔɚʈɋʂɹɞɇ¨ɜɩɽŤɭƱkɯɋʃŝɚʈɾʻʟʫʕɯĀɭɰɆɡɲŀɭÌɌBɦɨȻɳǻʈɩÿɜɌŜɩçÚɜɨɷɜɌɪÌɌɹɞɇǢǹɂɂ ĕƈɩɰəɛɌɹɞɑɆŤɭɋɣɦɨÊɔȀʂ@ɜɨȵɌɣĻĖĿ´4ŝɆŝĊɐʁňɐɔ[ɜɔəæ¦ɜɨɔɤɚʃľyĠ4ŝɆîƽŗʇďɌɨȵɌɣƍyŲɹɣɆŤʇƙŅūɭõóɜɨȵɌɣĄĖǂèƱɪ4ŝɆńƻĩ4ŝɭŁɔÖǢưɜɹɞɇăɭɘɯ~ʇɏ+ʂɜɨÆŹšɜɗɹɞɇĐÄɭɆŶƅɭÊɔ_ɖ7ʄɨɚɦɣLinda Hsieh-WilsonùêɆŶƅŝļʇʛʻˌʪɜɨɔʄʃ˃ʺʿˉ
ʰˌɆµȞɭʆɣʃʉʿ˄ʑÿāǁɭɒŃɦɨɔʄɣɭŁɔÖǢưɜɹɞɇɂɂ

Micromeeting Hɯ Linda ɪƈƥɂ ɂ ɂ29ɂ ɂ ʕ˄ʟʼʟʱˌʨʊˌɩɯʙʼ

1#DēąĘÊ Ê No. 45 (2014 July)

第８回 バイオ関連化学シンポジウム（第 29 回 生体機能関連化学シンポジウム、第 17 回 バイオテクノロジー部会シンポジウム、
第 17 回 生命化学研究会シンポジウム）

http://jointsympo.csj.jp/ =ȏ2014 ÷ 9 ı 11 ħȅĵȆȓ 13 ħȅÎȆ *ȏëêØÝ ŔìBbiWJ lƩġƤŁ
ȅëêò¯±Ŕìs 3-1-1JR ëêǽ5VJ" 15-20 Ȇ ȏħĶ®Ý―ũŇƦǨǘ®ÝǛV>AOCUhIkǛũŇƦǨǘ®ÝjV>
AOCUhIkP=XIciYhiO=<ũÆ®ÝŽƈ ȏħĶưÝǾ ÜÝǲŎ®Ý$ SȏĲŇÁč®Ý´ .ȏÌ'V>AǨǘ®Ý'ŽƈƢÝũ&47ŽƈŲƳ4*ƻǂ9Ʊ [ZNRjLiWCǍjǞƒ ÜƿǄjǎ ÜjaPfƏǚ ÜǨǘ%$õú V>AǨǘ®Ý'
0'ĊÑ|ě'Ò9Ě7ƬďŽƈƢ'Ƥč'0'ǃŝǌ'Ęq1Ʊ 
CLATI!ȏ 7 ı 2 ħȅŏȆ
F%FI!ȏ 7 ı 18 ħȅǢȆ&#DX[G\I!ȏ 7 ı 25 ħȅǢȆ&#AT9>ȏ
WEB G>Qȅhttp://jointsympo.csj.jpȆ 5ŲƳŮǒwƆ·Ɔ'Ě¸©ųǤ',!'ďƙ9Ʊ CL21ȏ¼Ƿ%5*&]JLk*¼ǷŲƳȅ15 ŲƳ5 Ǎű3 ÒȆ(·¦#!ȉŽƈáȉ."Ůǒ( 2."½'ÒÁ(ŲƳǵ9 2 ŷ'ęÄ(àƱÛÈ'¢Ĥ&47ǛǃŝǌȏũŇƦǨǘ®ÝǛ 7 (V>AOCUhIkǛ' 8'ǛÈ&%
!ȉ÷oƖǙ»ǌī 40 Đp'ǛÈäǇǌĆ­Ůǁ(ŲƳŮǒ/īŠ"»
9Ʊ &#DXRȏ
7 ı 25 ħȅ¸©ųǤȅwƑȆƜ¡Ȇ."ǛÈȏ lƩ 5,000 Ýũ 3,000  ǳǛÈȏlƩ 7,000 Ýũ 4,000 
7 ı 25 ħǪjjjoƼ'À¸©ƅ£& 2,000 ZdJ

30

1#DēąĘÊ Ê No. 45 (2014 July)* 8'Ŀ&1wƆǱǢÅ.8!
*wƆǱ'x§ǕĶ(wß! .:.

5Nȏ9 ı 12 ħȅǢȆ  ëêħƉ\OfȅJR ëêǽƵ¼§Ȇ
¸©Ǌ 6,000 -K+(ȏØńǾ¾ǼŊrƫǉ¾ŐǆçƐ
VHȏ ØńǾ¾ȅëêØÝØÝǫƨŢƂÝŽƈƂ®ÝũÆðÝåĞȆ
Tel : 086-251-8218, Fax: 086-251-8219, E-mail: ohtsuk@okayama-u.ac.jp
31

1#DēąĘÊ Ê No. 45 (2014 July)

第 41 回 国際核酸化学シンポジウム
The 41th International Symposium on Nucleic Acids Chemistry (ISNAC2014)
http://btl.nishitetsutravel.jp/niccs/isnac2014/:<ȏ2014 ÷ 11 ı 5 ħȅŏȆȓ7 ħȅǢȆ*ȏ¯vïÌǮǅÒȅƁëź¯vïòæ¯±ŕǡ 3-9-30Ȇ
ĶHi]I?_"(ȅȉȆĥŇƦ9ĖľǟǨǘÜ'®ÝÁčȅȊȆľǟǨǘV>AOCU

hIkȅȋȆľǟŃǗ&Ǩ7Ťŧ®ÝŵŽƈȅȌȆŇƦĈľǟ'ũŤŇƦj²ưĆū&Ǩ
7Žƈ%$ľǟ®Ý&Ǩ7Ǡƶ%ǡ&7İĥ'čĽŲƳ8..řÖ5

10 ~'ĔĀǃŝƢ9Ĕ.
63Q?Jȏ
Harald Schwalbe, Goethe Universitat Frankfurt, Germany
Jean-Jacques Toulme, Bordeaux University, France
Kumiko Ui-Tei, The University of Tokyo, Japan
Mitsuo Sekine, Tokyo Insititute of Technology, Japan
Peter Beal, UC Davis, USA
Ryszard Kierzek, Polish Academy of Sciences, Poland
W. David Wilson, Georgia State University, USA
Wojciech T. Markiewicz, Polish Academy of Sciences, Poland
Yves Mely, CNRS, France
Ta-Chau Chang, Institute of Atomic and Molecular Sciences & Genomics Research Center,
Academia Sinica, Republic of China
Sihyun Ham Sookmyung, Women's University, Korea
Robert H. E. Hudson, The University of Western Ontario, Canada




1. Chemistry of Nucleosides, Nucleotides, and Their Analogues
2. Medicinal Chemistry of Nucleosides and Oligonucleotides
3. DNA/RNA Chemistry and Biochemistry
4. DNA/RNA Structure and Recognition
5. Ribozymes, siRNAs, and miRNAs
6. DNA/RNA Materials and Diagnostics
7. Drug Delivery Systems and Nanotechnology of Oligonucleotidesƽ( web site 9Ƹ

http://btl.nishitetsutravel.jp/niccs/isnac2014/&#DX&#Rx§¸©ųǤ 2014 ÷ 6 ı 9 ħȓ10 ı 15 ħȅweb site 5Ȇ

32

1#DēąĘÊ Ê No. 45 (2014 July)x§ųǤ lƩ 25,000 Ýũ 5,000 ýħųǤ lƩ 30,000 Ýũ 7,000 
CLATȏ2014 ÷ 6 ı 9 ħȓ8 ı 8 ħȅweb site 5Ȇ

M;7ȏ2014 ÷ 6 ı 9 ħȓ10 ı 15 ħȅweb site 5Ȇ)'ȏƌsƝƞȅvïðłØÝȆ
E-mail:isnac2014@takenaka.che.kyutech.ac.jp

33

1#DēąĘÊ Ê No. 45 (2014 July)

第 24 回 バイオ・高分子シンポジウム
http://www.spsj.or.jp/entry/ ȏǾ ÜÝV>AȔǾ ÜŽƈ$ SȏħĶ®ÝħĶưÝĲŇÁč®Ý´ħĶũŤŤŧÝħĶ®ÝYhiO=<ũÆ®ÝŽƈ: <ȏöč 26 ÷ 7 ı 24 ħȅĵȆ25 ħȅǢȆȈČƹ 24 ħȅĵȆ *ȏĺ}ðłØÝƵ 9 ¿ǻ 2 ǭP=ILf×ŷŵ\kfȅŷȂ±Øëê 2-12-1Ȇ UȏĺćŷȂƛjĺćØ{ůƛØëêǽpǑĂŌƑ 3 .ȏV>AȔǾ Ü&!'Ðſ4*Ćū&Ǩ7Žƈŉ' ǡ&ȅȉȆ]e[ZNRLiWCǍ'~ðŇƦ®Ǟƒ'ŇƦĝÕȅȊȆľǟ#Ǩǘ®ÁŤȅȋȆ×Ǝ4*ƎǍǨq7ŇƦǾ ÜȅȌȆũƧ~ðƧ
ȅȍȆ~ð ÜƕƞȅȎȆƓƥŇƦ'¥ăƓƥ#Ǿ Ü'Źzū!(ť&ǠŠ9]
ƍȉħȑ7 ı 24 ħȅĵĚ
Ȑ10:30ȓ12:30Ȓ lƩŽƈŲƳ 1  20 ȅŽƈŲƳ 12 jƻǂ 8 Ȇ
Ȑ13:30ȓ15:50Ȓ ƬďŽƈƢÚªŲƳ 1  20 ȅŽƈŲƳ 12 jƻǂ 8
Ȑ16:00ȓ18:00Ȓ ]JLkŲƳ
Ȑ18:10ȓ20:00Ȓ Čƹƍ 2 ħȑ7 ı 25 ħȅǢĚ
Ȑ10:00ȓ12:00Ȓ lƩŽƈŲƳ 1  20 ȅŽƈŲƳ 12 jƻǂ 8 Ȇ
Ȑ13:00ȓ13:40Ȓ ť£ŲƳȏJkWkĒǞƒ'ŲƷ#èǧȅØ ØŽŇŃ/JST-CRESTȆlyn ĉƟȐ13:40ȓ16:20Ȓ lƩŽƈŲƳ 1  20 ȅŽƈŲƳ 12 jƻǂ 8 Ȇ&#MY]¸©ǊȅƄǒȆ tj´ǋËÈ lƩ 7,560 Ýũ 3,240 ČƹǊȅƄǒȆ lƩ 5,000 Ýũ 2,500 ŮǒĦœ pƼ HP 46Ůǒ/p Ůǒ/ÉÁ104-0042 ĺ}ǝsÙ±ƪ 3-10-9 ĥãůXf 6F Ǿ ÜÝV>AjǾ
TEL 03-5540-3771 FAX 03-5540-3737 jigyo@spsj.or.jp
http://www.spsj.or.jp/entry/34ȆÜHi]I?_1#DēąĘÊ Ê No. 45 (2014 July)

14-1 バイオ・高分子研究会
http://www.spsj.or.jp/entry/annaidetail.asp?kaisaino=964 ȏǾ ÜÝV>AjǾ ÜŽƈ: <ȏöč 26 ÷ 9 ı 26 ħȅǢȆ19:00 ȓ9 ı 27 ħȅÎȆ13:10
 *ȏ&3 :ĥǻjŀĻȀ ( 850-0041 ǥíòŖö 2 mŷ 14-1)
TELȏ 095-824-2153  FAXȏ095-824-5299
http://www.nisshokan.com/baishokaku/ Uȏ[Ʊ] JR ǥíØÝ5ǕǔVJ"Ƒ 20[ô6] JR ǥíǽ."ǕǔVJ 
ƍȉħ=9 ı 26 ħȅǢȆ<19:00ȓ> ČƹƍȊħ=9 ı 27 ħȅÎȆ<8:50ȓ9:35> 1. ǳyǠ5:ŃǗ&ǯ8ľǟ'ŇƦ9Ż7ȅŭµØÝƋũÆðÝŽƈĎȅFIBERȆȆķĶŸñ
<9:35ȓ10:20> 2. ľǟ&ƗÁ7 Ü9¨7jȅØǩØÝŪłƂÝŽƈĎƍȋŽƈǛǦȅũj ÜƂÝƏȆȆsǆÇþ
<10:40ȓ11:25> 3. ľǟ#×Ǝ'Źzū9 DDS #!ȅ¯vïòƊØÝÌǮŨÔðÝǛŨÔũÆðÝƂȆň{Çĳ<11: 25ȓ12:10> 4. Źzū9ZhDd_!ľǟ9 ļ7ȅţĶØÝØÝǫƨŢƂÝŽƈƂȆ{·Ġ¶<12:15ȓ13:10> ĪǺ<13:10> ǕǔVJŲ&#MY:1) ßÈ 50 Ã2) ¸©ǊȅƄǒjėǒł 5,400  ØÝjÞù 3,240  Ýũ 2,160  ÃƾjƔǐjY@hkjFkfRȆjHT<È 2,160  V>AjǾ ÜŽƈ`iVkȏšģ
3) âŒǊȅ1 Œ 3 ǺjýħĜđ Ȇ17,000  Ýũ 15,000 Čƹ(Žƈ'§ħ&ǧ.'""7 9 ı 26 ħ5¸© 9 ı 10
ħ(ŏ)Ǫ(BbiKfģŲũ.4) Ůǒ/Ħœ Ǿ ÜÝ\k_[kIȅhttp://www.spsj.or.jp/entry/Ȇ5'Ůǒ/'o¸©Ǌ'/9ǕǢp âŒǊ(ýħą¹ .ZhDd_(Õĭ&%7# .İĥĊÑ( HP "žƿ 5) Ůǒ/Ɯ0¡6 8 ı 22 ħ(Ǣ)6) ėǒ ǣƱėǒ nƯĺ} UFJ ǣƱ ǣüĜû (Ĭǖ) 1126232 ŶƀËœ~Ǿ ÜÝǜėį 00110-6-111688 ŶƀËœ~Ǿ ÜÝėǒďĢģ(ėǒ~&!ǈē .4 ǹ.
ǣƱjǜėį'Ƕ¹Į91.!Ķ5'Ƕ¹Į& ! .VHȏvïðłØÝŤǍðÝƏĆū®ÝǛǦ ƌsƝƞ E-mail: shige@che.kyutech.ac.jp
TEL/FAX: 093-884-3322
ATȏ 104-0042 ĺ}ǝsÙ±ƪ 3-10-9 ĥãůXf
ŶƀËœ~ Ǿ ÜÝ 14-1 V>AjǾ ÜŽƈ
http://www.spsj.or.jp/entry/
TEL 03-5540-3770 FAX 03-5540-3737

35

1#DēąĘÊ Ê No. 45 (2014 July)

人工光合成国際会議 20142014 International Conference on Artificial Photosynthesis (ICARP2014)
http://artificial-photosynthesis.net/ICARP2014/ ȏƂŽǊĥÝƲǶÏ~ðÁčƚĕŦ ȏJST ÛÕÔ×ÍüĊĒþĘç³>`ÎÃ9 =ȏ11 k 24 eękĚĜ28 eę»Ě *ȏP ~´A¢*6À±=
CLATI!ȏ8 k 20 eęyĚ
F%FI!ȏ8 k 20 eęyĚ&#DXGATI!ȏ9 k 20 eę7ĚOPZȏL-[êÒÐåæ|µÜåÐô,6ëÔÁÜËëçUë®Æê¼Ýô<0ç±¯ËÞÜå,6êÒ×ô¼·ċĔăûÿćë­f÷Áê¦ÐíÝÌ
CL21ȏ)Ä¨ęÅ°ëîĚçČĄąĘ¨ÌČĄąĘ²Ïó
@"Q?ȏ¥K gęqBĚěsJ¤ęPurdue Univ. & JSTĚĠEġ

63Q?ȏRichard CogdellęUniv. GlasgowĚěHuub de GrootęUniv. LeidenĚěDevens GustęArizona State
Univ.ĚěSang Ook KangęKorea Univ.ĚěCan LięDalian Inst. Chem. Phys.ĚěThomas MeyeręUniv. North CarolinaĚěDaniel NoceraęHarvard Univ.ĚěLicheng SunęKTH Royal Inst. Tech.Ěě
John TurneręNatl. Renewable Energy Lab.ĚěRienk van GrondelleęFree Univ. AmsterdamĚě
Michael WasielewskięNorthwestern Univ.ĚěKyung Byung YoonęSogang Univ.Ěě;[ęqBĚěę½BĚě{QęIHBĚéè

CLAT9>ȏ¬Ğğñó&#DXRȏ£ 40,000 ËDė.

25,000 ęoie@dëZ«çnëhÇêì'3÷V^TĚÌéÒË9 k 21 e¾ìË,ĝùĆċçéóíÝÌ
AT)'ȏICARP2014 !F w 8ę1ÈBĚ
E-mail: icarp2014@artificial-photosynthesis.net
http://artificial-photosynthesis.net/ICARP2014/36

1#DēąĘÊ Ê No. 45 (2014 July)

第 17 回 生命化学研究会〜生命化学の大海原を探る〜

http://res.tagen.tohoku.ac.jp/FBC/ ȏħĶ®ÝYhiO=<ũÆ®ÝŽƈ =ȏ2015 ÷ 1 ı 8 ħȅĵȆ13 ī ȓ 9 ħȅǢȆ12 ī *ȏnơÍȅ

780-0862 ǾŻòȁ°ů 1-3-35jTEL: 088-822-0131Ȇ             http://www.sansuien.co.jp/ȏȉȇǾŻȃǼƉŜ5 ǘƘVJȅǾŻǽƱȆ&uǑ(6.2ņƺVJLk^SfpǑƑ 40

ȕ720 

Ȋȇ(6.2ņ5 ǏǴǲǑ9¤ū(6.2ņ→źù§ŰĎpǑāĂŌȋ
15

ƃ Ƒ

ȕ200

ȋȇJR ǾŻǽ5 ǏǴǲǑ"(6.2ņuěƑ 20

ȕ200ȆQ 08EB
ȏķêǰlȅŧŽȆØÓƭøȅĺðØŧðȆŋğǀȅĨØŧðȆŞŬ«ȅ¯ǬƋØȆśsƮŅȅ}ØðȆĵÊŘȅ}ØðȆǾìƠĄȅǩØŧȆĻŗÇ¦ȅǿºØðȆ Rȏ¸©ųǤǊ 13,000 âŒǊ 10,000 Ǻx 7,000 ȅýħą¹Ȇ
&#AT9>ȏōÃjĎéjÿƣȅÝ÷ȆjE-mail <RgJj]JLkŲƳ'óĴ'Ĳš9ĩƼ'o11/18ȅşȆ."&pƼ'ǘƘ+Ůǒ/, (ȏ80 Ã ]JLkŲƳ­ǱȅĢ( 40 ǓȆ
M;I!ȏ11/18ȅşȆ]JLkŲƳóĴƢ( A4 ŴȂ³[kIOiZgkQ9ū!ƴŮǒ/ī&ŚY;>f#!pƼǘƘǓǕ! OiZgkQ(ũÆ®ÝŽƈ\k_[kIȅhttp://res.tagen.tohoku.ac.jp/FBC/Ȇ46M?ihkR".
%]JLkǸŷ(Ĺ7Ʀ¬ċ"¬ŵ%L>Qf9 !p ȅȏ__(__" 7__(____7Ȇ)' VHȏ
558-8585 ØǩòÂ±ķĶ 3-3-138 ØǩòƊØÝØÝǫðÝŽƈƂ®ÝũŤƏåĞ ǥȄ 
E-mailȏnagasaki@bioa.eng.osaka-cu.ac.jp
Tel: 06-6605-2696  Fax: 06-6605-2785

37

1#DēąĘÊ Ê No. 45 (2014 July)  ę1ÈBDÊ c_Ě
M[25NOÊ 315 ep#DD§²
ChhY=f'ŃǗ#ŇƦ&Ǩ7Žƈę2014N3kĚ

 /W 4
ǢőðłØÝV>Aj®ÝǛĆū®ÝƂ ġĘ
2014÷1ı1ħ
924-0838 żîźŴêòĸƇ 3-1 2 -eGkNBbiWJ EU_ũŤðÝŽƈĎ
E-mail: shinono@neptune.kanazawa-it.ac.jp38

1#DēąĘÊ Ê No. 45 (2014 July)ÊNðßöÐë?+ęNo. 45Ě÷ÒG×ÝôÙçÔæÕíÜàÌÒXÜÐË:ÜåÛãàÛøêìWÓòÒÜØíÝÌÊ ÛåËÙÑÜå45+ëÁt÷¦ãåÐôëìāĆýĘĕĘĒĈýĆċëãjæÝÌmËepìÓéó\Ü¶îéÔòð10ëþđĂĎçRÕ×åÜíÐíÜàÌ

Ùõæz"T¸ìÓéó&ÜÖéãàñÑæÝÌx÷(óÜåvëuÜî÷îä×éÐ ç… Ëč Ę / ë ā ú ėď Ė Ā ² ?ËC  ç¹ Ú Ý ?  î ?ËÞ Ü å S-JĂ Ė Č in
Bern?…ÌÊ v+ęNo. 46ĚìËr}Ûøë]SêñóË2014N10kÂë¦÷EÜåÒóíÝÌ
ĉĐĘĄēąĘa4ëàïËÛøÓòëÚ©lËÚYª÷ÒTâÜåÒóíÝÌ¬Á]SíæÚ·÷Ðàá8)ø

"
M[26N6k20e%b$
pBDBD¿¡Dętoshi@chem.kumamoto-u.ac.jpĚÁ]SÊ BCę ºBDĚÊ r}2ęÉ(BDĚ39